Questions

1. Neuroimaging Findings & Diagnosis:
   • Neuroimaging shows widespread, asymmetric, poorly demarcated, patchy hyperintensities on T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequences involving the subcortical and deep cerebral white matter, brainstem, cerebellar peduncles, and deep grey nuclei (thalamus and basal ganglia).
   • Primary diagnosis: Acute Disseminated Encephalomyelitis (ADEM).
2. IPMSSG Diagnostic Criteria:
   • A first polyfocal clinical central nervous system (CNS) event of presumed inflammatory demyelinating etiology.
   • Encephalopathy (altered consciousness or behavioral change not explained by fever, systemic illness, or postictal state).
   • Brain MRI during the acute phase showing diffuse, poorly demarcated, large (>1–2 cm) T2/FLAIR lesions predominantly affecting cerebral white matter (deep grey matter lesions may also be present).
   • No new clinical or MRI findings emerging $\ge 3\text{ months}$ after symptom onset.
3. Immunomodulatory Management:
   • First-line Therapy:
     • Intravenous Methylprednisolone: $30\text{ mg/kg/day}$ (maximum $1000\text{ mg/day}$) administered as a slow infusion over 1 hour once daily for 3–5 days.
     • Followed by an oral prednisolone taper: $1\text{ to }2\text{ mg/kg/day}$ tapered gradually over 4–6 weeks to prevent rebound demyelination.
   • Second-line Therapy (for steroid-refractory cases or severe fulminant presentation):
     • Intravenous Immunoglobulin (IVIG): $2\text{ g/kg}$ total dose administered over 2 to 5 days ($0.4\text{ g/kg/day}$ for 5 days or $1\text{ g/kg/day}$ for 2 days).
     • Therapeutic Plasma Exchange (PLEX): 5 to 7 cycles on alternate days.
4. Prognosis & Recurrence:
   • Prognosis: Favorable in $80\%\text{ to }90\%$ of pediatric patients, achieving complete or near-complete neurological recovery over several weeks to months.
   • Recurrence: Approximately $10\%$ develop a subsequent event (multiphasic ADEM); persistent recurrences warrant investigation for Myelin Oligodendrocyte Glycoprotein antibody-associated disease (MOGAD) or Multiple Sclerosis (MS).

1. Radiological Abnormality & Location:
   • Abnormality: Aspirated fractured/avulsed tooth (dental fragment) appearing as a triangular/crown-shaped radiopaque foreign body.
   • Location: Right main bronchus (at the level of the bronchus intermedius).
2. Anatomical Basis for Right Bronchial Predisposition:
   • The right main bronchus has a larger internal caliber (wider diameter) than the left main bronchus.
   • The right main bronchus diverges at a steeper, more vertical angle relative to the long axis of the trachea (approximately $25^\circ$ from the vertical midline compared to $45^\circ$ for the left).
   • The carina is situated slightly to the left of the midline, directing a greater proportion of inspired airflow and aspirated particulate matter into the right lung.
3. Definitive Intervention:
   • Rigid Bronchoscopy under general anesthesia with optical grasping forceps in the operating theatre.
4. Complications:
   • Immediate Complications: Complete proximal airway obstruction leading to asphyxia; tension pneumothorax or pneumomediastinum secondary to bronchial laceration; ball-valve hyperinflation of the right lung.
   • Delayed Complications: Obstructive atelectasis/collapse; recurrent post-obstructive pneumonia; localized bronchiectasis; lung abscess or bronchial granulation/stricture formation.

1. Device Identification & Structural Feature:
   • Device: Armored (reinforced / flexometallic) endotracheal tube.
   • Structural Feature: Spiral-wound metal (stainless steel) or nylon wire embedded circumferentially within the tube wall along its entire flexible shaft.
2. Surgical Indications:
   • Surgeries requiring prone or lateral positioning (e.g., neurosurgical, posterior spine, or scoliosis corrections).
   • Head, neck, and maxillofacial surgery involving extreme neck flexion, extension, or head rotation.
   • Shared airway procedures (e.g., cleft palate repair, tonsillectomy, oral and dental surgery).
   • Submental or retromolar intubations where acute tube angulation is required to maintain surgical access.
3. Hazards / Disadvantages:
   • Irreversible luminal obstruction if bitten: If the patient bites down on the non-reinforced portion or crushes the wire spiral, it flattens and does not re-expand, causing complete luminal occlusion that necessitates immediate emergency re-intubation.
   • Need for a stylet during intubation: Because the tube is exceedingly flexible, it lacks inherent directional memory and usually requires a lubricated stylet for introduction, which increases the risk of airway trauma.
   • Inability to trim the proximal tube: Cutting the tube risks exposing sharp wire ends, which limits shortening to minimize dead space.
4. Mathematical Derivation:
   $$ > \begin{aligned} > \text{Cuffed ETT ID (mm)} &= \frac{\text{Age in years}}{4} + 3.5 \\ > &= \frac{8}{4} + 3.5 \\ > &= 2 + 3.5 = \mathbf{5.5\text{ mm ID}} > \end{aligned} > $$
   $$ > \begin{aligned} > \text{Insertion Depth at Lip (cm)} &= \frac{\text{Age in years}}{2} + 12 \quad (\text{or } \text{ETT ID} \times 3) \\ > &= \frac{8}{2} + 12 = \mathbf{16\text{ cm}} \quad (5.5 \times 3 = 16.5\text{ cm}) > \end{aligned} > $$

1. Radiological Abnormality:
   • Dense, bilateral, symmetrical calcifications prominently involving the basal ganglia (globus pallidus, putamen, and caudate nuclei), with variable extension into the thalamus, centrum semiovale, and cerebellar dentate nuclei.
2. Endocrine & Metabolic Etiologies:
   • Idiopathic or autoimmune hypoparathyroidism.
   • Pseudohypoparathyroidism (Albright Hereditary Osteodystrophy).
   • Pseudopseudohypoparathyroidism.
   • Mitochondrial encephalomyopathies (e.g., Kearns-Sayre syndrome, MELAS).
   • Biotin-thiamine-responsive basal ganglia disease.
3. Non-Endocrine Etiologies:
   • Primary Familial Brain Calcification (Fahr Disease): Autosomal dominant/recessive mutations in SLC20A2, PDGFB, PDGFRB, XPR1, or MYORG.
   • Congenital TORCH Infections: Particularly Cytomegalovirus (CMV) and Toxoplasmosis.
   • Aicardi-Goutières Syndrome: Hereditary interferonopathy presenting with intracranial calcifications and leukodystrophy.
   • Toxic / Hypoxic Encephalopathy: Carbon monoxide poisoning, lead intoxication, or profound perinatal asphyxia.
4. Initial Laboratory Evaluation Panel:
   • Total and ionized serum calcium.
   • Serum inorganic phosphorus (elevated in hypoparathyroidism/pseudohypoparathyroidism).
   • Serum intact Parathyroid Hormone (iPTH) level (suppressed in hypoparathyroidism, elevated in pseudohypoparathyroidism).
   • Serum magnesium level (hypomagnesemia can cause functional hypoparathyroidism).
   • Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels.
   • Serum alkaline phosphatase and 24-hour urinary calcium-to-creatinine ratio.

1. Scintigraphy Findings & Diagnosis:
   • Findings: Prompt and adequate hepatic uptake of the radiopharmaceutical from the blood pool, with persistent liver parenchymal activity and complete absence of tracer excretion into the biliary tree, gallbladder, and small intestine on serial views up to 24 hours.
   • Diagnosis: Biliary Atresia.
2. Radiopharmaceutical & Premedication Protocol:
   • Radiopharmaceutical: Technetium-99m labeled iminodiacetic acid derivatives (e.g., $^{99\text{m}}\text{Tc}$-Mebrofenin or $^{99\text{m}}\text{Tc}$-DISIDA).
   • Pharmacological Premedication: Oral Phenobarbital administered at $5\text{ mg/kg/day}$ divided every 12 hours for 3 to 5 consecutive days prior to the scan to stimulate hepatic microsomal enzymes and maximize biliary excretion, thereby reducing false-positive rates from severe intrahepatic neonatal cholestasis.
3. Definitive Surgical Operation & Optimal Age Window:
   • Procedure: Kasai Hepatoportoenterostomy (resection of the atretic extrahepatic biliary tract and reconstruction with a Roux-en-Y jejunal loop).
   • Optimal Age Window: Before 60 days of life ($<8\text{ weeks}$). Surgical success drops considerably when performed between 60 and 90 days, and carries a poor long-term native liver survival rate when executed beyond 90 days due to irreversible biliary cirrhosis.
4. Fat-Soluble Vitamin Supplementation Protocol:
   • Vitamin A: Water-miscible Vitamin A (Aquasol A) at $5,000\text{ to }10,000\text{ IU/day}$ orally.
   • Vitamin D: 25-hydroxycholecalciferol (Calcifediol) at $3\text{ to }5\text{ mcg/kg/day}$ orally, or Cholecalciferol / Ergocalciferol at $2,000\text{ to }5,000\text{ IU/day}$ orally.
   • Vitamin E: d-alpha-tocopheryl polyethylene glycol-1000 succinate (TPGS) at $15\text{ to }25\text{ IU/kg/day}$ (or $50\text{ to }400\text{ IU/day}$) orally.
   • Vitamin K: Phytonadione (Vitamin $\text{K}_1$) at $2.5\text{ to }5\text{ mg}$ orally 2 to 3 times per week (or $1\text{ to }2\text{ mg/day}$ orally; monthly parenteral intramuscular doses if intestinal malabsorption is severe).
   • Ursodeoxycholic Acid (UDCA): $15\text{ to }20\text{ mg/kg/day}$ orally divided in 2 to 3 doses to augment bile acid-dependent canalicular flow.

1. Neuroimaging Findings:
   • Well-defined, smooth, thin, ring-enhancing hypodense intracerebral lesion (typically in the parieto-occipital or frontal region).
   • Marked perilesional vasogenic edema appearing as finger-like hypodense projections.
   • Mass effect evidenced by effacement of adjacent cortical sulci, compression of the ipsilateral lateral ventricle, and midline shift.
2. Diagnosis and Mechanism:
   • Diagnosis: Brain Abscess (Cerebral Abscess).
   • Pathophysiology: Right-to-left intracardiac shunt bypasses the pulmonary capillary circulation, which normally acts as an anatomic filter for circulating microemboli and bacteremia. Concurrent chronic hypoxemia and secondary polycythemia elevate blood viscosity, causing focal microvascular sludging, microthrombosis, and localized tissue ischemia that serves as a fertile nidus for hematogenous microbial seeding.
3. Four Stages of Brain Abscess (Britt & Enzmann Criteria):
   • Early cerebritis (Days 1–3): Ill-defined localized inflammatory infiltrate, petechiae, and localized non-enhancing or patchy edema.
   • Late cerebritis (Days 4–9): Central necrotic core with maximal surrounding vasogenic edema; patchy or thick rim enhancement.
   • Early capsule formation (Days 10–13): Reticulin and collagen deposition forming a thin vascularized rim; discrete ring enhancement.
   • Late capsule formation (Day 14 onwards): Mature, dense collagenous capsule with marked central liquefaction and prominent surrounding gliosis.
4. Medical Management & Surgical Indications:
   • Empirical Regimen:
     • Ceftriaxone: 100 mg/kg/day IV divided q12h (max: 4 g/day) OR Cefotaxime 200–300 mg/kg/day IV divided q6–8h
     • PLUS Metronidazole: 30 mg/kg/day IV divided q8h (max: 1.5–2 g/day)
     • PLUS Vancomycin: 60 mg/kg/day IV divided q6h (target trough 15–20 µg/mL; max: 2–4 g/day)
     • Total duration: 4 to 6 weeks of targeted parenteral therapy (confirmed by follow-up neuroimaging resolution).
   • Indications for Neurosurgical Intervention (Aspiration/Excision):
     • Lesion diameter > 2.5–3 cm.
     • Significant mass effect, severe midline shift, or impending cerebral herniation.
     • Periventricular location with high risk of intraventricular rupture.
     • Lack of clinical improvement or progressive enlargement after 2 weeks of medical therapy.

flowchart TD
    A[Cyanotic Congenital Heart Disease] --> B[Right-to-Left Shunt]
    A --> C[Chronic Hypoxia & Polycythemia]
    B --> D[Bypasses Pulmonary Phagocytic Capillary Filter]
    C --> E[Microvascular Sludging & Focal Cerebral Infarction]
    D & E --> F[Direct Seeding of Transient Bacteremia into Ischemic Brain]
    F --> G[Cerebritis Phase: Days 1-9]
    G --> H[Capsule Formation: Days 10+]
    H --> I[Mature Ring-Enhancing Brain Abscess]

1. Anatomical Structures:
   • A: Head of the caudate nucleus.
   • B: Lentiform nucleus (Putamen and Globus pallidus).
   • C: Anterior limb of the internal capsule.
   • D: Genu of the internal capsule.
   • E: Posterior limb of the internal capsule.
   • F: Thalamus.
   • G: Third ventricle.
   • H: Genu of the corpus callosum.
2. Vascular Supply:
   • Head of caudate (A): Recurrent artery of Heubner (medial striate branch of anterior cerebral artery) and medial/lateral lenticulostriate arteries of middle cerebral artery (MCA).
   • Lentiform nucleus (B): Lateral lenticulostriate branches of the middle cerebral artery (putamen and outer globus pallidus); anterior choroidal artery (inner globus pallidus).
   • Posterior limb of internal capsule (E): Lateral lenticulostriate arteries (superior portion) and anterior choroidal artery from the internal carotid artery (inferior/retrolenticular portion).
3. Preferential Deep Gray Matter Targets:
   • Carbon monoxide poisoning: Bilateral symmetric necrosis of the Globus Pallidus.
   • Wilson disease: Putamen and Globus Pallidus (Lenticular nucleus), followed by the caudate and thalamus (producing the "double panda" sign on midbrain MRI).
   • Kernicterus: Bilateral symmetric involvement of the Globus Pallidus and Subthalamic Nuclei (with preservation of the putamen).
4. Myelination Signal Characteristics:
   • Neonate (Unmyelinated): High water content and low hydrophobic lipid content; white matter appears T1-hypointense and T2-hyperintense relative to gray matter.
   • Mature Brain (Age ≥2 years): Extensive myelination with dense sphingomyelin, galactocerebroside, and cholesterol deposition; white matter appears T1-hyperintense and T2-hypointense relative to gray matter.

1. Pathognomonic Radiographic Signs:
   • Anteroposterior (AP) View: "Double-ring" or "halo" sign (concentric radiopaque rings produced by the stepped bilaminar configuration of the smaller cathode overlapping the larger anode can).
   • Lateral View: "Step-off" sign (beveled or stepped profile at the interface between the anode and cathode cans, distinct from the smooth flat edge of a coin).
2. Pathophysiologic Mechanisms of Injury:
   • Generation of External Microcurrent (Primary): Lodgment in the moist esophageal lumen conducts an electrical current between poles, generating rapid water electrolysis at the negative pole (anode) that produces concentrated sodium hydroxide (alkaline caustic liquefactive necrosis).
   • Alkaline Electrolyte Leakage: Rupture or venting of caustic internal contents (potassium or sodium hydroxide).
   • Physical Ischemic Pressure Necrosis: Luminal compression of esophageal mucosa impeding capillary microperfusion.
3. Life-Threatening Complications:
   • Esophageal perforation with acute necrotizing mediastinitis, tension pneumothorax, or subcutaneous emphysema.
   • Aortoenteric (Aortoesophageal) Fistula: Leads to catastrophic, fatal sentinel exsanguination.
   • Tracheoesophageal Fistula: Leads to acute airway inundation, flooding, and severe chemical aspiration pneumonitis.
4. Emergency Management Protocol:
   • Emergent Endoscopy: Mandatory rigid or flexible endoscopic removal within < 2 hours of presentation if lodged in the esophagus.
   • Pre-procedural Mitigation (if ingestion <12 hours, child >1 year, without suspected perforation):
     • Administer Honey: 10 mL orally every 10 minutes (up to 6 doses) OR
     • Administer Sucralfate suspension: 10 mL orally every 10 minutes (up to 3 doses) to coat the battery, neutralize alkaline microenvironment, and attenuate tissue injury.
   • Post-Removal Management:
     • Grade mucosal injury endoscopically.
     • Keep strictly NPO, initiate IV broad-spectrum antibiotics and high-dose proton pump inhibitors.
     • If deep muscularis propria injury or transmural ulceration is noted, perform CT angiography of the chest to rule out pseudoaneurysm formation.
     • Keep under observation for delayed hemorrhage; sentinel minor bleeding can precede catastrophic aortoesophageal rupture by up to 18–28 days.

1. Diagnosis and Subsite:
   • Diagnosis: Neonatal Clavicular Fracture (Right-sided).
   • Most Common Subsite: Middle third (mid-shaft) of the clavicle (accounts for approximately 75–80% of cases, representing the transition zone between two opposing curves where cross-sectional bone density is narrowest).
2. Clinical Differentiation:
   • Clavicular Fracture: "Pseudoparalysis" due to pain. Active distal wrist/hand movement is intact, grasp reflex is present, Moro reflex is asymmetrically inhibited by pain, and localized bony crepitus, focal edema, or tenderness is palpable over the bone.
   • Erb-Duchenne Palsy (C5-C6): True flaccid neuromuscular paralysis. Arm is held characteristically in adduction and internal rotation with elbow extension, forearm pronation, and wrist flexion ("waiter's tip" posture). Biceps jerk is absent; grasp reflex is preserved; passive motion is painless without bony crepitus.
   • Septic Arthritis of Shoulder: True joint immobility with profound pain on all passive glenohumeral rotations, joint effusion/erythema, systemic toxicity/fever, and elevated serum inflammatory markers (CRP, procalcitonin).
3. Callus Timeline and Neurovascular Examination:
   • Callus Formation: Palpable firm, non-tender nodule appears within 7 to 14 days; dense radiological callus bridging is visible between 10 and 21 days.
   • Neurovascular Assessment:
     • Brachial plexus trunks (assess distal motor power and grasp reflex).
     • Subclavian vessels (palpate radial and brachial pulses, evaluate capillary refill time ≤2 seconds, and inspect for expanding hematoma or pallor/cyanosis of the distal extremity).
4. Management and Remodeling Physiology:
   • Conservative Therapy: Analgesia (Paracetamol 10–15 mg/kg/dose orally every 6–8 hours PRN) and gentle immobilization by pinning the infant's long sleeve to the anterior chest wall with the elbow flexed to 90 degrees for 7 to 10 days. Avoid direct pressure on the affected side during nursing and handling.
   • Remodeling Basis: Neonatal periosteum is thick, metabolically hyperactive, and osteogenic. Enormous longitudinal growth potential of the adjacent epiphyseal growth plates and continuous biomechanical stress guarantee complete skeletal remodeling of angulation and displacement within 6 to 12 months, leaving no residual deformity or functional deficit.

1. Radiological Findings:
   • Chest Radiograph: Complete aplasia or hypoplasia/dysplasia of the clavicles (predominantly involving the acromial/lateral ends), small bell-shaped thorax, and hypoplastic scapulae.
   • Skull Radiograph: Widely patent anterior and posterior fontanelles, delayed closure of cranial sutures (sagittal, coronal, metopic), multiple intrasutural intercalary bones (Wormian bones producing a mosaic appearance), underdeveloped paranasal sinuses, and hypoplastic maxilla.
2. Diagnosis and Genetics:
   • Diagnosis: Cleidocranial Dysplasia (CCD).
   • Causative Gene: Heterozygous mutation in the RUNX2 (Runt-related transcription factor 2, also known as CBFA1) gene.
   • Chromosomal Location: Chromosome 6p21.1.
   • Inheritance: Autosomal dominant (approximately one-third represent de novo mutations).
3. Craniofacial and Dental Abnormalities:
   • Dental: Prolonged retention of primary (deciduous) dentition, failure/delay of permanent tooth eruption, multiple impacted supernumerary teeth (often secondary premolars), and severe malocclusion.
   • Craniofacial: Frontal and parietal bossing, midface hypoplasia, hypertelorism, depressed nasal bridge, high-arched or cleft palate, and conductive hearing loss secondary to Eustachian tube dysfunction.
4. Multidisciplinary Management:
   • Dental Protocol: Combined staged surgical-orthodontic approach: timely extraction of retained deciduous teeth and obstructive supernumerary teeth, followed by surgical exposure and orthodontic traction/extrusion of unerupted permanent teeth.
   • Cranial Protection: Protective headgear (helmets) during high-impact sports and contact activities due to large calvarial defects and persistent unossified fontanelles.
   • Audiology: Regular screening for recurrent middle ear effusions and conductive hearing loss; prompt insertion of tympanostomy tubes if indicated.

1. Radiological Findings:
   • Dense consolidation involving the left mid- and lower-zones with air bronchograms.
   • Well-defined, thick-walled radiolucent cavity containing an internal air–fluid level within the consolidated lung parenchyma.
   • Blunting of the ipsilateral left costophrenic angle indicating an associated parapneumonic effusion / empyema.
   • Mediastinal and cardiac shift toward the contralateral (right) side secondary to mass effect.
2. Diagnosis & Causative Organisms:
   • Radiological Diagnosis: Necrotizing pneumonia / lung abscess with parapneumonic effusion.
   • Causative Organisms: Staphylococcus aureus (specifically methicillin-resistant S. aureus [MRSA] or Panton-Valentine leukocidin [PVL]-producing strains) and Streptococcus pneumoniae (notably serotypes 3, 19A).
3. Bedside Diagnostic/Therapeutic Interventions:
   • Diagnostic thoracocentesis and/or ultrasound-guided intercostal chest tube (ICD) drainage (8–12 Fr) with underwater seal for pleural fluid analysis and decompression.
   • Thoracic point-of-care ultrasound (POCUS) to evaluate fluid volume, assess loculations/septations, and guide pigtail catheter placement or intrapleural fibrinolytics (e.g., urokinase/tPA).
4. Antimicrobial Regimen:
   • Anti-MRSA Therapy: Intravenous Vancomycin 60 mg/kg/day divided every 6 hours (15 mg/kg/dose IV q6h, infused over 60 minutes; targeting a trough level of 15–20 mcg/mL) OR Intravenous Linezolid 30 mg/kg/day divided every 8 hours (10 mg/kg/dose IV q8h).
   • Broad-Spectrum Gram-Negative Coverage: Intravenous Cefotaxime 150–200 mg/kg/day divided every 6–8 hours OR Intravenous Ceftriaxone 75–100 mg/kg/day once daily or divided every 12 hours.
   • Total Duration: Minimum 3 to 4 weeks (at least 2 weeks of parenteral therapy until afebrile and clinically improved, followed by oral step-down therapy to complete 21–28 days).

1. Computed Tomography Findings:
   • Prominent punctate and curvilinear periventricular calcifications lining the subependymal margins of the lateral ventricles (anterior and occipital horns).
   • Generalized cerebral volume loss with ex-vacuo ventriculomegaly and prominent extra-axial CSF spaces (widened Sylvian and interhemispheric fissures).
   • Cortical developmental malformations (simplified gyral pattern / pachygyria or polymicrogyria).
2. Diagnosis & Ophthalmological Finding:
   • Diagnosis: Congenital Cytomegalovirus (CMV) infection.
   • Ocular Finding: Chorioretinitis (exudative perivascular white-yellow retinal lesions with retinal hemorrhages, commonly evolving into chorioretinal scarring and optic atrophy).
3. Diagnostic Confirmation:
   • Neonatal Period (≤ 21 days of life): Detection of CMV DNA by real-time Polymerase Chain Reaction (RT-PCR) in saliva or urine (sensitivity and specificity > 95%).
   • Beyond 21 Days of Life: Retrospective CMV PCR testing performed on archived neonatal dried blood spots (Guthrie card) collected at birth (to differentiate congenital from postnatally acquired CMV transmission).
4. Antiviral Therapy:
   • First-Line Drug: Oral Valganciclovir solution.
   • Dose & Route: 16 mg/kg/dose orally, administered twice daily (every 12 hours).
   • Duration: Total duration of 6 months.
   • (Alternative for non-tolerating oral route: Intravenous Ganciclovir 6 mg/kg/dose IV every 12 hours for 6 weeks, followed by oral valganciclovir to complete 6 months).

1. Radiographic Findings:
   • Marked hyperinflation and hyperlucency of the left upper pulmonary zone with attenuation/spacing out of bronchovascular markings.
   • Significant shift of the cardiothymic silhouette and mediastinal structures into the contralateral (right) hemithorax.
   • Compressive atelectasis of the ipsilateral left lower lobe and contralateral lung.
   • Flattening and depression of the ipsilateral left hemidiaphragm, with anterior herniation of the overinflated lobe across the midline retrosternal space.
2. Diagnosis & Site Predilection:
   • Diagnosis: Congenital Lobar Emphysema (CLE) / Congenital Lobar Overinflation (CLO).
   • Most Common Lobe: Left Upper Lobe (~40–50% of cases), followed by Right Middle Lobe (~30%) and Right Upper Lobe (~20%).
3. Differential Diagnoses:
   • Congenital Pulmonary Airway Malformation (CPAM, Type 1 or 2 with large micro/macrocysts).
   • Tension pneumothorax.
   • Tracheobronchial foreign body aspiration or mucus plugging causing a ball-valve obstruction.
   • Congenital diaphragmatic hernia (prior to bowel gas entry).
4. Definitive Management & Anesthetic Precautions:
   • Definitive Treatment: Open or thoracoscopic lobectomy of the affected lung lobe.
   • Anesthetic Precautions:
     • Avoid high positive-pressure ventilation and bag-mask hyperventilation prior to thoracotomy to prevent progressive dynamic air trapping, tension emphysema, and acute cardiovascular collapse.
     • Avoid the use of Nitrous Oxide ($N_2O$) as it rapidly diffuses into compliant gas-filled spaces and exacerbates lobe distension. Maintain gentle spontaneous or low-pressure assisted ventilation until the pleura is decompressed.

1. Malformation in Exhibit A:
   • Identity: Grey Matter Heterotopia (specifically Periventricular Nodular Heterotopia [PNH] or Subcortical Band Heterotopia).
   • MRI Signal Characteristics: Isointense to normal grey matter cortex on all MRI pulse sequences (T1-weighted, T2-weighted, and FLAIR), showing no abnormal post-gadolinium enhancement, restricted diffusion, or surrounding vasogenic edema.
2. Malformation in Exhibit B:
   • Identity: Schizencephaly.
   • Subtypes:
     • Closed-lip (Type I): The cleft walls are fused and in direct apposition; there is no intervening continuous CSF column connecting the ventricle to the subarachnoid space, but the cleft is lined by dysplastic grey matter.
     • Open-lip (Type II): The cleft walls are widely separated; a full-thickness, continuous CSF-filled gap extends from the lateral ventricle to the pial surface, lined by heterotopic/polymicrogyric grey matter.
3. Embryological Disruption:
   • Exhibit A (Heterotopia): Disorder of neuronal migration (arrest of radial neuroblast migration along radial glial fibers from the periventricular germinal zone to the nascent neocortex between 8 and 16 weeks of gestation).
   • Exhibit B (Schizencephaly): Early primary post-migrational vascular disruption or localized ischemic necrosis involving radial glia and cerebral mantle, or abnormal post-migrational cortical organization (typically before the 7th gestational month).
4. Genetics & Vascular Complication:
   • Gene Mutation: FLNA gene mutation (encoding Filamin A) on chromosome Xq28 (X-linked dominant; causes periventricular nodular heterotopia in females and is typically embryonic lethal in hemizygous males).
   • Vascular Complication: Thoracic/abdominal aortic aneurysm, aortic dissection, or associated cardiac valvulopathy and patent ductus arteriosus.

1. Modality & Target Vessel:
   • Modality: Transfontanellar pulsed-wave spectral Doppler ultrasonography (Cranial Doppler).
   • Target Vessel: Anterior Cerebral Artery (ACA) along the pericallosal groove in the midsagittal plane.
2. Resistive Index (Pourcelot Index):
   $$ \begin{aligned} \text{Resistive Index (RI)} &= \frac{\text{Peak Systolic Velocity (PSV)} - \text{End-Diastolic Velocity (EDV)}}{\text{Peak Systolic Velocity (PSV)}} \end{aligned} $$
   • Normal Reference Range: $0.60 - 0.80$ (in healthy term neonates after transitional stabilization).
3. Calculation & Interpretation:
   $$ \begin{aligned} \text{RI} &= \frac{\text{PSV} - \text{EDV}}{\text{PSV}} \\ &= \frac{40 - 22}{40} \\ &= \frac{18}{40} = \mathbf{0.45} \quad (\text{Normal: } 0.60 - 0.80) \end{aligned} $$
   • Interpretation: Abnormally low resistive index ($\text{RI} = 0.45 < 0.55$). This indicates cerebral vasoparalysis with loss of cerebrovascular autoregulation, leading to luxury perfusion / hyperperfusion injury.
4. Prognostic Implications in HIE:
   • Low RI (< 0.55): Signifies profound cerebral vasodilation secondary to uncoupled autoregulation and secondary energy failure. Strongly predictive of severe neurodevelopmental disability, extensive basal ganglia/cortical necrosis, microcephaly, or neonatal mortality.
   • High RI (> 0.85 or absent/reversed end-diastolic flow): Indicates high downstream intracranial cerebrovascular resistance, resulting from massive cerebral edema with raised intracranial pressure (ICP), impending brain death, or severe systemic hypotension compressing the cerebral microvasculature.

1. Neuroimaging Features:
   • CT: Well-circumscribed, heterogeneous sellar/suprasellar mass demonstrating nodular and rim-like calcification along with low-attenuation cystic components.
   • MRI: Complex solid-cystic lesion compressing the optic chiasm and third ventricle; cystic fluid displays T1 hyperintensity (cholesterol- and protein-rich "machine oil" fluid) and T2 hyperintensity, with robust contrast enhancement of the solid mural components and cyst walls.
2. Diagnosis & Histological Subtype:
   • Diagnosis: Craniopharyngioma.
   • Subtype: Adamantinomatous craniopharyngioma (driven by somatic CTNNB1 mutations, featuring wet keratin, adamantinomatous epithelium, and calcifications; unlike the papillary subtype seen almost exclusively in adults).
3. Classic Clinical Triad:
   • Raised intracranial pressure: Headache, vomiting, and papilledema due to obstruction of the foramen of Monro / third ventricle producing hydrocephalus.
   • Visual disturbance: Bitemporal hemianopia and optic atrophy resulting from superior compression of the optic chiasm.
   • Endocrine dysfunction: Growth failure (GH deficiency), delayed puberty (gonadotropin deficiency), central diabetes insipidus, and secondary hypothyroidism/adrenal insufficiency from hypothalamic-pituitary axis destruction.
4. Definitive Management & Endocrine Protocol:
   • Surgical intervention: Maximal safe resection via endoscopic endonasal transsphenoidal approach or open pterional/transcranial craniotomy.
   • Adjuvant radiation: Intensity-modulated radiation therapy (IMRT) or proton beam therapy for residual or recurrent solid/cystic disease.
   • Perioperative endocrine coverage:
     • Stress-dose hydrocortisone: $50\text{--}100\text{ mg/m}^2/\text{day}$ IV divided q6h perioperatively, tapered to maintenance ($8\text{--}10\text{ mg/m}^2/\text{day}$).
     • Fluid and electrolyte management: Strict hourly fluid intake/output and urine specific gravity monitoring to detect postoperative triphasic response (transient DI $\rightarrow$ SIADH $\rightarrow$ permanent central DI); desmopressin (DDAVP) titrated at $0.05\text{--}0.1\text{ mcg}$ IV/subcutaneously or $2.5\text{--}5\text{ mcg}$ intranasally for hypernatremia with polyuria (urine output $>4\text{ mL/kg/hr}$).

1. Radiological Sign & Pathophysiology:
   • "Double bubble" sign.
   • The first, larger gas bubble represents the dilated, air-fluid-filled stomach in the left upper quadrant; the second, smaller gas bubble represents the dilated first and second portions of the duodenum to the right of midline, with a complete absence of gas throughout the distal gastrointestinal tract.
2. Definitive Diagnosis & Embryology:
   • Duodenal atresia (intrinsic complete duodenal obstruction).
   • Failure of recanalization and vacuolization of the primitive solid duodenal cord during the 8th to 10th weeks of gestation.
3. Associated Conditions:
   • Chromosomal anomaly: Trisomy 21 (Down syndrome, present in ~30% of cases).
   • Pancreatic anomaly: Annular pancreas (due to failure of the ventral pancreatic bud to rotate posteriorly, constricting the second part of the duodenum).
4. Pre-operative Resuscitation & Surgical Correction:
   • Acute medical stabilization:
     • Decompression: Continuous or intermittent low-pressure suction via an 8–10 Fr Replogle or nasogastric sumptube.
     • Fluid/electrolyte correction: IV fluid rehydration with $10\%$ Dextrose in $0.45\%$ Normal Saline with $20\text{ mEq/L}$ KCl (once urine output $>1\text{ mL/kg/hr}$) to correct hypokalemic, hypochloremic metabolic alkalosis.
   • Definitive surgery: Kimura diamond-shaped duodenoduodenostomy (anastomosis between proximal transverse duodenal incision and distal longitudinal incision) via laparotomy or laparoscopy.

1. Image A - Imaging Pattern & Diagnosis:
   • Symmetrical, bilateral hyperintensities on T2/FLAIR sequences involving the posteromedial thalami, basal ganglia (putamen and globus pallidus), midbrain (substantia nigra), and upper brainstem, often with microhemorrhages on SWI/GRE.
   • Diagnosis: Japanese Encephalitis (JE).
2. Image B - Imaging Pattern & Diagnosis:
   • Asymmetric, striking hyperintensity on T2/FLAIR involving the medial temporal lobes, hippocampus, insular cortex, and inferior frontal gyri (sparing the basal ganglia), with restricted diffusion on DWI.
   • Diagnosis: Herpes Simplex Encephalitis (HSE, caused by HSV-1).
3. Pharmacotherapy for Patient B:
   • Intravenous Acyclovir.
   • Dose: $20\text{ mg/kg/dose}$ IV (or $500\text{ mg/m}^2/\text{dose}$) every 8 hours, infused over 1 hour with adequate hydration to prevent crystal nephropathy.
   • Duration: 21 days in pediatric CNS disease (re-evaluate CSF HSV PCR prior to cessation).
4. Neuro-Intensive Care Strategies for Patient A:
   • Airway protection and neuro-ventilation: Endotracheal intubation if GCS $\le 8$; maintain normocapnia ($\text{PaCO}_2$ $35\text{--}40\text{ mmHg}$) and hyperoxygenation ($\text{PaO}_2 > 100\text{ mmHg}$).
   • Head positioning and posture: Head of bed elevated to $30^\circ$ in the midline neutral position to maximize cerebral venous drainage.
   • Osmotherapy: $3\%$ Hypertonic saline ($3\text{--}5\text{ mL/kg}$ IV bolus, target serum sodium $145\text{--}155\text{ mEq/L}$) or $20\%$ Mannitol ($0.5\text{--}1\text{ g/kg}$ IV over 20 minutes, monitoring serum osmolality $<320\text{ mOsm/kg}$).
   • Seizure termination and prophylaxis: IV Levetiracetam loading at $40\text{--}60\text{ mg/kg}$ followed by $30\text{ mg/kg/day}$ divided q12h; maintain normothermia ($<37.5^\circ\text{C}$) using active cooling devices.

1. Radiological Sign & Diagnosis:
   • "Thumbprint sign" (or "thumb sign") caused by marked swelling and rounded enlargement of the epiglottis, accompanied by thickened aryepiglottic folds and obliteration of the vallecular air space.
   • Diagnosis: Acute Epiglottitis.
2. Etiological Agents:
   • Classic pathogen: Haemophilus influenzae type b (Hib).
   • Emerging pathogens in vaccinated cohorts:
     • Streptococcus pyogenes (Group A Streptococcus).
     • Streptococcus pneumoniae.
     • Staphylococcus aureus (including Methicillin-Resistant S. aureus [MRSA]).
3. Clinical Contraindications During Initial Triage:
   • Do not perform oral/pharyngeal examination with a tongue depressor (risk of precipitating complete reflex laryngospasm).
   • Do not force the child into a supine position; allow the child to maintain their preferred position of comfort (tripod position) in a parent's arms.
   • Do not perform agitating procedures (such as painful venipunctures, IV cannulation, or separation from parents) before securing the airway in an operating room.
4. Definitive Airway & Antimicrobial Protocol:
   • Airway Management: Immediate transfer to the operating theater; inhalational induction with sevoflurane in $100\%\text{ O}_2$ and endotracheal intubation by an experienced pediatric anesthesiologist or intensivist using an endotracheal tube 0.5 to 1.0 mm smaller than expected for age, with ENT surgeon scrubbed on standby for rigid bronchoscopy or emergency surgical cricothyroidotomy/tracheostomy.
   • Empirical IV Antibiotic Therapy:
     • Ceftriaxone: $100\text{ mg/kg/day}$ IV once daily (or divided q12h; max $4\text{ g/day}$) OR Cefotaxime: $150\text{--}200\text{ mg/kg/day}$ IV divided q6-8h.
     • PLUS Vancomycin: $40\text{--}60\text{ mg/kg/day}$ IV divided q6h (max $2\text{ g/day}$) for coverage against MRSA and resistant streptococci. Total duration: 7 to 10 days.

1. Radiological Description & Diagnosis:
   • Markedly elevated, smooth, unbroken, dome-shaped contour of the right hemidiaphragm reaching the mid-to-upper thorax, with compression atelectasis of the adjacent right middle and lower lung lobes, and preserved costophrenic angles.
   • Diagnosis: Eventration of the diaphragm (right-sided).
2. Distinctions from Congenital Diaphragmatic Hernia (CDH):
   • Anatomical: Eventration features an intact, continuous, but severely thinned, hypoplastic, or fibroelastic diaphragmatic sheet; CDH involves a complete structural defect/aperture through which intra-abdominal viscera herniate directly into the pleural space without an intact diaphragmatic boundary.
   • Radiological: Eventration presents with a continuous, unbroken, smooth arched line capping the abdominal contents; CDH demonstrates intrathoracic gas-filled bowel loops, absence of the normal diaphragmatic contour, and mediastinal shift.
3. Dynamic Diagnostic Evaluation:
   • Test: Real-time dynamic chest ultrasonography or fluoroscopy (M-mode ultrasound / sniff test).
   • Expected finding: Paradoxical cephalad (upward) movement of the affected thinned hemidiaphragm during inspiration (or rapid sniffing), or complete immobility, while the normal contralateral hemidiaphragm moves caudally (downward).
4. Indications for Surgery & Surgical Technique:
   • Clinical indications:
     • Recurrent or intractable lower respiratory tract infections/pneumonias.
     • Significant respiratory compromise, dyspnea on exertion, or ventilatory failure.
     • Failure to thrive, gastrointestinal symptoms (gastric volvulus, reflux), or inability to wean from mechanical ventilation.
   • Surgical procedure: Diaphragmatic plication (reefing/folding of the redundant, attenuated membranous diaphragm using non-absorbable interrupted or running sutures, performed via open thoracotomy, laparotomy, or minimally invasive VATS/laparoscopy).

1. Radiological Findings and Diagnosis:
   • CT Findings: Well-demarcated, hyperdense (50–70 Hounsfield Units), biconvex (lenticular) extra-axial collection in the left temporoparietal region that does not cross cranial suture lines (bounded by coronal and lambdoid sutures), exerting mass effect with effacement of adjacent sulci and ipsilateral lateral ventricle, accompanied by overlying subgaleal soft tissue hematoma.
   • Diagnosis: Acute left temporoparietal extradural (epidural) hemorrhage (EDH).
2. Vascular Anatomy & Clinical Phenomenon:
   • Vessel: Middle meningeal artery (frontal/anterior branch) or its accompanying venae comitantes traversing the foramen spinosum underlying the thin squamous temporal bone at the pterion.
   • Phenomenon: Lucid interval (temporary clearance of mental state between the initial concussive blow and the subsequent progressive neurological deterioration from mass effect).
3. Hematoma Volume Calculation:
   $$ > \begin{aligned} > C &= \text{Slice thickness} \times \text{Number of slices} = 0.5 \text{ cm} \times 8 = 4.0 \text{ cm} \\ > \text{Hematoma Volume } (V) &= \frac{A \times B \times C}{2} \\ > &= \frac{6.0 \text{ cm} \times 2.5 \text{ cm} \times 4.0 \text{ cm}}{2} \\ > &= \mathbf{30.0 \text{ cm}^3} > \end{aligned} > $$
   • Interpretation: A volume of $\ge 30 \text{ cm}^3$ meets the absolute threshold criterion for emergency operative evacuation regardless of the patient's Glasgow Coma Scale (GCS) score.
4. Operative Indications and Medical Management:
   • Neurosurgical Indications for Evacuation:
     • Hematoma volume $> 30 \text{ cm}^3$ regardless of GCS.
     • EDH thickness $> 15 \text{ mm}$ or midline shift $> 5 \text{ mm}$.
     • GCS score $< 9$ with pupillary asymmetry or anisocoria $> 2 \text{ mm}$.
     • Progressive focal neurological deficits or acute neurological deterioration ($\ge 2$ point drop in GCS).
   • Osmotherapy for Acute ICP Elevation:
     • Hypertonic (3%) Saline: $3\text{--}5 \text{ mL/kg}$ IV bolus over 10–20 minutes (or continuous infusion of $0.1\text{--}1.0 \text{ mL/kg/hour}$ targeting serum sodium 145–155 mEq/L and serum osmolality $< 360 \text{ mOsm/kg}$).
     • Mannitol (20%): $0.25\text{--}1.0 \text{ g/kg}$ ($1.25\text{--}5.0 \text{ mL/kg}$) IV infusion over 20–30 minutes through an in-line filter (maintain serum osmolality $< 320 \text{ mOsm/kg}$, provided patient is normovolemic).

1. Radiological Findings:
   • Plain Abdominal Radiograph: Marked, single, monstrously distended gas-filled viscous cavity occupying the upper abdomen and left hypochondrium/epigastrium with a prominent air-fluid level, downward displacement of transverse colon, and complete absence of distal bowel gas (gasless lower abdomen). Diaphragmatic contours are intact with no subdiaphragmatic free air.
   • Tube Check Radiograph: Nasogastric tube seen arrested or curling in the lower thoracic esophagus / gastroesophageal junction, failing to enter the gastric lumen.
2. Diagnosis and Classification:
   • Definitive Diagnosis: Acute gastric volvulus.
   • Anatomical Subtypes:
     • Organoaxial (59%): Rotation around the long axis connecting the cardia and pylorus (greater curvature flips anteriorly and superiorly; associated with diaphragmatic defects/strangulation).
     • Mesenteroaxial (29%): Rotation around the short vertical axis connecting the lesser and greater curvatures (pylorus rotates anteriorly and superiorly to lie above the gastroesophageal junction; usually unassociated with diaphragmatic hernias).
   • Differential Diagnosis: Acute gastric dilatation secondary to aerophagia, tension gastropneumothorax / congenital diaphragmatic hernia with intrathoracic stomach, or gastric outlet obstruction with localized perforation.
3. Classic Clinical Triad:
   • Borchardt's Triad:
     • Severe, sudden-onset epigastric pain and distension.
     • Violent, non-productive retching with inability to vomit.
     • Inability to pass a nasogastric/orogastric tube into the stomach.
4. Resuscitation and Definitive Management:
   • Immediate Resuscitation:
     • Aggressive IV fluid resuscitation for hypovolemic/obstructive shock: Isotonic balanced crystalloid (Plasmalyte or 0.9% Normal Saline) bolus of $20 \text{ mL/kg}$ IV push over 10–15 minutes, repeated as needed.
     • Nil per os (NPO) and broad-spectrum IV antibiotics (e.g., Ampicillin-Sulbactam $50 \text{ mg/kg/dose}$ IV q6h plus Gentamicin $7.5 \text{ mg/kg/day}$ IV single dose).
     • Attempt careful decompression under fluoroscopy/endoscopy or bedside percutaneous trocar gastric puncture if gastric ischemia/respiratory collapse is imminent.
   • Definitive Surgical Intervention:
     • Emergency laparotomy / laparoscopy: Derotation of volvulus, assessment of gastric viability (resection of non-viable tissue).
     • Anterior gastropexy (suturing greater curvature to anterior abdominal wall) or gastrostomy tube placement (anchors stomach).
     • Repair of predisposing secondary defects (e.g., congenital diaphragmatic hernia, eventration, or absent gastrocolic/gastrosplenic ligaments).

1. Anatomical Site and Sonographic Diagnosis:
   • Site: Caudothalamic groove (caudothalamic notch), situated between the head of the caudate nucleus anteriorly and the thalamus posteriorly, immediately subependymal to the floor of the frontal horn of the lateral ventricle.
   • Diagnosis: Acute subependymal germinal matrix hemorrhage (confined to the caudothalamic notch without intraventricular extension).
2. Papile Ultrasound Classification:
   • Grade I: Subependymal germinal matrix hemorrhage alone (or hemorrhage occupying $< 10\%$ of lateral ventricular area).
   • Grade II: Intraventricular hemorrhage (IVH) occupying 10% to 50% of the lateral ventricular lumen without ventricular dilatation.
   • Grade III: Intraventricular hemorrhage occupying $> 50\%$ of the lateral ventricular lumen with acute lateral ventricular dilatation.
   • Grade IV: Germinal matrix / intraventricular hemorrhage with associated periventricular hemorrhagic infarction (venous infarction of the medullary veins into periventricular white matter).
3. Microvascular and Anatomical Pathophysiology:
   • Fragile Microvasculature: The subependymal germinal matrix possesses a dense, highly metabolically active capillary network lined only by a single layer of endothelial cells devoid of muscular basement membrane support, tight junctions, or mature pericytic coverage.
   • U-Shaped Venous Drainage: Terminal, choroidal, and striate veins converge into the internal cerebral vein making a sharp hairpin ("U-turn") loop at the caudothalamic groove, generating high venous stasis and pressure.
   • Impaired Autoregulation: Preterm infants exhibit pressure-passive cerebral circulation; rapid swings in arterial blood pressure (from hypercapnia, hypoxia, rapid fluid boluses, or endotracheal suctioning) directly transmit elevated hydrostatic pressure to fragile capillaries, precipitating rupture.
   • Increased Fibrinolytic Activity: High intrinsic concentrations of tissue plasminogen activator (tPA) in the germinal matrix impede stable clot formation.
4. Screening Protocol and Long-Term Sequelae:
   • Screening Schedule (AAP/NNF Guidelines):
     • First screening CrUS: Postnatal days 3 to 7 (detects 90% of hemorrhages).
     • Second screening CrUS: Postnatal day 14 or at 4 to 6 weeks of age (evaluates for post-hemorrhagic ventricular dilatation and cystic periventricular leukomalacia).
     • Term-equivalent CrUS or Brain MRI: At 36–40 weeks postmenstrual age (prior to NICU discharge).
   • Long-Term Neurodevelopmental Sequelae:
     • Spastic cerebral palsy (specifically asymmetric spastic hemiplegia or diplegia).
     • Post-hemorrhagic hydrocephalus requiring ventriculoperitoneal shunt or ventricular reservoir.
     • Neurosensory impairments (sensorineural hearing loss, cortical visual impairment) and intellectual disability.

1. Radiological Findings:
   • Plain axial CT of the head (bone window) demonstrates a full-thickness, non-depressed linear fracture of the left occipital bone extending toward the lambdoid suture with mild diastasis ($> 2 \text{ mm}$ cortical gap separation), along with prominent overlying extracranial soft-tissue subgaleal swelling (scalp hematoma).
2. Pediatric Glasgow Coma Scale (pGCS) Calculation:
   $$ > \begin{aligned} > \text{Eye Opening }(E) &= 2 \quad (\text{Opens eyes to pain only}) \\ > \text{Verbal Response }(V) &= 2 \quad (\text{Incomprehensible sounds / grunts}) \\ > \text{Motor Response }(M) &= 4 \quad (\text{Withdraws from pain}) \\ > \text{Total pGCS} &= E2 + V2 + M4 = \mathbf{8} / 15 > \end{aligned} > $$
   • Severity Classification: Severe traumatic brain injury (TBI defined as GCS $\le 8$; moderate is GCS 9–12; mild is GCS 13–15).
3. PECARN Algorithm Criteria ($\ge 2$ Years of Age):
   • High-Risk Criteria (Risk of ciTBI $\sim 4.3\%$; CT recommended immediately):
     • Glasgow Coma Scale score $< 15$ (or altered mental status including agitation, somnolence, slow verbal responses).
     • Signs of basilar skull fracture (hemotympanum, "raccoon eyes" periorbital ecchymosis, Battle's sign, CSF otorrhea/rhinorrhea).
   • Intermediate-Risk Criteria (Risk of ciTBI $\sim 0.9\%$; observation for 4–6 hours vs CT based on clinician judgment/worsening):
     • History of any loss of consciousness (even brief).
     • History of vomiting.
     • Severe mechanism of injury (fall $> 5 \text{ feet}$ or $> 1.5 \text{ meters}$, motor vehicle crash with ejection, rollover, pedestrian hit by car, bike collision without helmet).
     • Severe or worsening headache.
4. Primary Survey and Resuscitation (ATLS ABCDE):
   • A - Airway with Cervical Spine Protection: Immediate endotracheal intubation indicated for GCS $\le 8$; perform rapid sequence intubation (RSI) maintaining manual in-line cervical stabilization (MILS). Pre-medicate to prevent ICP spikes.
   • B - Breathing & Ventilation: Maintain normocapnia ($\text{PaCO}_2$ 35–40 mmHg; avoid prophylactic hyperventilation unless active uncal herniation is occurring); target $\text{SpO}_2 \ge 95\%$.
   • C - Circulation with Hemorrhage Control: Secure two large-bore peripheral IV lines; avoid hypotension (maintain systolic BP $> 5\text{th}$ percentile for age: $\ge 70 + [2 \times \text{age}] = 74 \text{ mmHg}$; target $> 90 \text{ mmHg}$ in TBI); administer isotonic balanced crystalloids.
   • D - Disability: Rapid baseline pupillary exam, assess for herniation; administer 3% hypertonic saline ($3\text{--}5 \text{ mL/kg}$ IV) if pupillary dilation or posturing develops.
   • E - Exposure / Environmental Control: Log-roll with spine precautions to inspect the entire spine and back; prevent hypothermia (maintain normothermia $36.5\text{--}37.5^\circ\text{C}$).

1. Radiological Findings and Diagnosis:
   • CT Findings: Axial pelvic CT demonstrates an outpouching/herniation of a peritoneal sac containing mesenteric fat and gas-filled loops of small bowel traversing through the left deep inguinal ring into the left inguinal canal, positioned anteromedial to the femoral vessels. No signs of bowel wall thickening, mural hypoperfusion, pneumatosis intestinalis, or localized fluid collection.
   • Diagnosis: Left-sided indirect inguinal hernia (uncomplicated/reducible).
2. Anatomical and Embryological Differentiation:
   • Embryological Origin:
     • Indirect: Congenital persistence / failure of obliteration of the processus vaginalis (peritoneal outpouching).
     • Direct: Acquired weakness/attenuation of the transversalis fascia in the posterior wall of the inguinal canal.
   • Relation to Inferior Epigastric Vessels:
     • Indirect: Arises lateral to the inferior epigastric artery and vein.
     • Direct: Arises medial to the inferior epigastric artery and vein (within Hesselbach's triangle).
   • Deep Inguinal Ring Involvement:
     • Indirect: Passes directly through the deep (internal) inguinal ring and traverses the length of the inguinal canal within the spermatic cord coverings.
     • Direct: Does not pass through the deep inguinal ring; bulges directly forward through Hesselbach's triangle floor.
3. Acute Complications:
   • Incarceration: Irreducible entrapment of bowel loops or omentum within the hernia sac causing mechanical bowel obstruction.
   • Strangulation: Compromise of mesenteric vascular supply leading to bowel wall ischemia, necrosis, gangrene, and secondary peritonitis/septic shock.
   • Testicular Infarction / Atrophy: Mechanical compression of the testicular artery and pampiniform venous plexus within the tight external/internal inguinal ring leading to gonadal ischemia.
4. Pediatric vs Adult Repair & Operative Timing:
   • Surgical Technique Differences:
     • Pediatric Repair: Simple herniotomy (high dissection and suture ligation of the patent processus vaginalis sac at the level of the internal ring). The posterior canal wall is anatomically normal; therefore, no posterior wall reconstruction or prosthetic mesh placement is performed.
     • Adult Repair: Hernioplasty / Herniorrhaphy (tension-free prosthetic polypropylene mesh repair, e.g., Lichtenstein repair, or posterior wall repair like Shouldice) due to acquired structural weakness of the transversalis fascia.
   • Timing of Repair:
     • In children, repair should be scheduled promptly / electively within days to a few weeks of diagnosis because of the high lifetime risk of incarceration ($12\text{--}30\%$, highest in young infants).
     • If incarceration occurs and is successfully manually reduced, surgery is performed within 24 to 4

1. NCCT Brain Findings:
   • Hyperdense intraparenchymal hematoma (typically frontoparietal or lobar) with surrounding hypodense vasogenic/cytotoxic edema.
   • Associated subdural or subarachnoid hyperattenuation.
   • Mass effect demonstrated by effacement of the ipsilateral lateral ventricle, sulcal effacement, and midline shift across the falx cerebri.
2. Definitive Diagnosis and Onset:
   • Diagnosis: Late Vitamin K Deficiency Bleeding (VKDB) / Late Hemorrhagic Disease of the Newborn presenting with acute intracranial hemorrhage.
   • Classification: Late VKDB occurs between 2 to 24 weeks of life (peak incidence at 4 to 8 weeks), predominantly in exclusively breastfed infants lacking parenteral vitamin K prophylaxis at birth.
3. Coagulation Profile Findings:
   • Prothrombin Time (PT): Markedly prolonged (often > 60–120 seconds or unmeasurable).
   • International Normalized Ratio (INR): Markedly elevated (> 4.0 to > 8.0).
   • Activated Partial Thromboplastin Time (aPTT): Markedly prolonged (due to deficiency of factors IX, X, and II).
   • Platelet Count: Normal (150,000–450,000/µL).
   • Plasma Fibrinogen: Normal (200–400 mg/dL).
4. Immediate Emergency Stabilization:
   • Airway & Breathing: Rapid sequence intubation with cervical spine control; target mild hyperventilation ($PaCO_2$ 30–35 mmHg) only if signs of imminent uncal herniation exist.
   • Vitamin K Replacement: Phytomenadione (Vitamin K1) 1 to 2 mg slow IV push over 15–30 minutes (reverses deficiency within 4–6 hours).
   • Rapid Coagulation Reversal:
     • Fresh Frozen Plasma (FFP): 10 to 15 mL/kg IV over 30–60 minutes, OR
     • Four-factor Prothrombin Complex Concentrate (PCC): 25 to 50 IU/kg IV (preferred for instantaneous reversal with minimal volume load).
   • Antiseizure Therapy: Levetiracetam 20 to 30 mg/kg IV bolus or Phenobarbital 20 mg/kg IV over 20 minutes.
   • Neurosurgical Intervention: Immediate external ventricular drainage (EVD) or decompressive craniotomy with hematoma evacuation once coagulopathy is corrected.
5. National Preventive Guidelines (Ministry of Health & Family Welfare / IAP):
   • All newborns weighing $\ge 1000\text{ g}$: Vitamin K1 (Phytomenadione) 1.0 mg intramuscularly (IM) within 1 hour of birth.
   • Preterm newborns weighing $< 1000\text{ g}$: Vitamin K1 0.5 mg IM within 1 hour of birth.

graph TD
    A[Absence of At-Birth IM Vitamin K1] --> B[Depletion of Factors II, VII, IX, X, Protein C, S]
    B --> C[Severe Coagulopathy: Markedly Elevated PT/INR and aPTT]
    C --> D[Intracranial Hemorrhage: Subdural / Intraparenchymal]
    D --> E[Cerebral Edema + Mass Effect + Midline Shift]
    E --> F[Immediate Reversal: IV Phytomenadione + FFP or PCC + Surgical Decompression]

1. Radiological Findings:
   • Image A: Dense, triangular, wedge-shaped opacity in the right upper pulmonary zone with a sharply demarcated, elevated, and inferiorly concave minor (horizontal) fissure, consistent with acute right upper lobe (RUL) atelectasis (collapse). Trachea is mildly deviated to the ipsilateral (right) side.
   • Image B: Complete re-expansion and clearing of the right upper lobe atelectasis with full aeration of the right lung field and normalization of the tracheal position.
2. Supportive and Monitoring Devices:
   • Invasive:
     • Endotracheal tube (ETT) with its tip situated in the mid-trachea (1.5–2 cm above the carina).
     • Enteric feeding tube (nasogastric or orogastric tube) passing below the diaphragm into the stomach.
   • Non-invasive:
     • Electrocardiographic (ECG) monitoring chest leads and cables.
     • Pulse oximetry cable/temperature probe lead.
3. Pathophysiological Mechanisms:
   • Impaired Cough Mechanics: Intercostal and abdominal muscle weakness prevents the generation of peak expiratory cough flow ($< 160\text{ L/min}$), causing inability to clear thick mucus plugs.
   • Tracheobronchial Geometry and Recumbency: The right upper lobe bronchus branches at an acute angle; in supine, immobilized patients, secretions pool preferentially in dependent apical and posterior segments under low gravitational clearance.
4. Airway Clearance Techniques:
   • Mechanical Insufflation-Exsufflation (CoughAssist): Positive pressure breath followed by rapid switch to negative pressure (e.g., $+30\text{ cmH}_2\text{O}$ to $-30\text{ cmH}_2\text{O}$).
   • High-Frequency Chest Wall Oscillation (HFCWO / airway vest therapy).
   • Postural drainage with manual chest percussion and vibration over the right upper chest.
   • Targeted fiberoptic bronchoscopic suctioning or endotracheal deep suctioning with saline lavages.
5. Indirect Radiologic Signs of Upper Lobe Collapse:
   • Elevation of the ipsilateral hemidiaphragm (juxtaphrenic peak sign / tenting).
   • Ipsilateral mediastinal and tracheal deviation.
   • Compensatory hyperinflation of the middle and lower lobes (increased lucency and splaying of vessels).
   • Elevation of the right pulmonary hilum.

1. Radiological Findings:
   • Disease-related: Complete homogeneous radiopacification ("whiteout") of the right hemithorax with obliteration of the right costophrenic angle, hemidiaphragm, and right heart border; widening of the right intercostal spaces; and marked contralateral displacement (shift to the left) of the trachea, mediastinum, and cardiac silhouette.
   • Treatment/Monitoring-related: Right-sided intercostal chest tube (ICD) entering via the 5th/6th intercostal space in the mid-axillary line; radio-opaque ECG monitoring leads overlying the thorax.
2. Mediastinal Shift Differentiation:
   • Massive Pleural Effusion (Space-occupying / Positive Pressure): Generates positive intrathoracic hydrostatic pressure, pushing the trachea, mediastinum, and cardiac silhouette contralaterally (away from the side of the lesion).
   • Complete Lung Collapse (Volume Loss / Negative Pressure): Generates high negative intrapleural suction pressure due to resorption of trapped alveolar gas, pulling the trachea, mediastinum, and cardiac silhouette ipsilaterally (toward the side of the lesion), accompanied by crowding of rib spaces.
3. Etiological Differentials:
   • Tuberculous pleural effusion.
   • Pediatric thoracic malignancy (T-cell lymphoblastic lymphoma, neuroblastoma, pleuropulmonary blastoma, Ewing sarcoma/Askin tumor).
   • Chronic/subacute empyema thoracis or unresolved parapneumonic effusion.
   • Chylothorax (congenital lymphatic malformation or occult trauma/obstruction).
4. Light's Criteria for Exudative Effusion:
   The fluid is classified as an exudate if one or more of the following criteria are met:
   • Pleural Fluid Protein to Serum Protein Ratio:
     $$\frac{\text{Pleural Fluid Total Protein}}{\text{Serum Total Protein}} > 0.5$$
   • Pleural Fluid LDH to Serum LDH Ratio:
     $$\frac{\text{Pleural Fluid LDH}}{\text{Serum LDH}} > 0.6$$
   • Pleural Fluid LDH Level:
     $$\text{Pleural Fluid LDH} > \frac{2}{3} \times \text{Upper Limit of Normal Serum LDH}$$

1. Radiological Features:
   • Coarse, irregular, rope-like, patchy infiltrates/densities radiating bilaterally from the hila into peripheral lung fields.
   • Marked hyperinflation/overexpansion with flattening and depression of the bilateral hemidiaphragms ($> 8\text{ to }9$ posterior ribs visible above diaphragm).
   • Areas of atelectasis/airspace consolidation interspersed with regions of hyperlucent air trapping.
   • Presence of pulmonary air leaks (pneumothorax, pneumomediastinum, or pneumopericardium).
2. Diagnosis:
   • Meconium Aspiration Syndrome (MAS).
3. Pathophysiological Mechanisms:
   • Mechanical Airway Obstruction: Complete terminal obstruction produces patchy micro-atelectasis; partial obstruction creates a "ball-valve" effect leading to alveolar hyperinflation and barotrauma/volutrauma (air leaks).
   • Chemical Pneumonitis: Meconium-derived bile salts, enzymes, and free fatty acids induce an acute release of pro-inflammatory cytokines (TNF-$\alpha$, IL-1$\beta$, IL-6, IL-8), causing alveolar-capillary membrane disruption and pulmonary edema.
   • Surfactant Inactivation and Consumption: Free fatty acids in meconium displace surfactant from the alveolar air-liquid interface, reducing pulmonary compliance.
   • Persistent Pulmonary Hypertension of the Newborn (PPHN): Acute hypoxemia, acidosis, and vascular remodeling trigger sustained high pulmonary vascular resistance (PVR), producing right-to-left shunting across the ductus arteriosus and foramen ovale.
4. Advanced Rescue Therapies:
   • Exogenous Surfactant Replacement Therapy: Poractant alfa ($200\text{ mg/kg}$ or $2.5\text{ mL/kg}$) or Beractant ($100\text{ mg/kg}$) administered intratracheally to overcome surfactant inactivation.
   • Dilute Surfactant Lung Lavage: Bronchoalveolar lavage using dilute surfactant (e.g., $15\text{ mL/kg}$ aliquots of diluted surfactant) to wash out particulate meconium.
   • Inhaled Nitric Oxide (iNO): Commenced at 20 ppm for documented PPHN with an Oxygenation Index (OI) $> 20$ to selectively dilate pulmonary vasculature.
   • High-Frequency Oscillatory Ventilation (HFOV): Facilitates lung recruitment at lower peak airway pressures while eliminating $CO_2$ in cases of severe air leaks or diffuse consolidation.
   • Extracorporeal Membrane Oxygenation (ECMO): Venoarterial (VA) or Venovenous (VV) ECMO as definitive bridge therapy when OI remains $> 40$ despite maximal medical support.

1. Hallmark Radiological Findings:
   • Image A (CXR): Large, well-circumscribed radiodense mass in the anterior/superior mediastinum causing marked widening of the cardiothymic silhouette, lateral displacement of the heart borders, and posterior/contralateral displacement of the trachea.
   • Image B (CECT Chest): Large, sharply marginated, heterogeneous anterior mediastinal mass displaying multi-tissue attenuation characteristics: cystic/fluid attenuation, soft-tissue attenuation, areas of macroscopic fat attenuation (negative Hounsfield units: $-30\text{ to }-100\text{ HU}$), and discrete foci of coarse calcification/ossification, causing extrinsic compression of the trachea and superior vena cava.
2. Diagnosis and Compartment:
   • Diagnosis: Mature or Immature Mediastinal Teratoma (Germ Cell Tumor).
   • Compartment: Anterior (prevascular) mediastinum.
3. Serum Oncological Biomarkers:
   • Alpha-fetoprotein ($\alpha$-FP).
   • Beta-human chorionic gonadotropin ($\beta$-hCG).
4. Critical Complications (Mediastinal Mass Syndrome):
   • Tracheobronchial airway collapse / severe tracheomalacia (lumen compression $> 50\%$).
   • Superior Vena Cava (SVC) syndrome (obstruction leading to facial/upper extremity cyanosis and edema).
   • Extrinsic compression of the pulmonary artery, right ventricular outflow tract (RVOT), or right atrium causing cardiogenic shock.
   • Rupture into the pleural/pericardial cavity or tracheobronchial tree (causing acute chemical pleuritis/pericarditis or acute hemoptysis).
5. Definitive Treatment and Histological Factor:
   • Definitive Treatment: Complete surgical excision via median sternotomy or anterior thoracotomy.
   • Histological Determinant for Adjuvant Therapy: Presence and grade of immature neuroepithelial tissue (Immature Teratoma, Norris Grade 2 or 3) or presence of malignant non-teratomatous germ cell tumor elements (e.g., yolk sac tumor foci), which necessitates adjuvant platinum-based combination chemotherapy (PEB: Cisplatin, Etoposide, Bleomycin).

1. Identified Neuroanatomical Structures:
   • Structure A: Corpus callosum (hypoechoic band bridging the cerebral hemispheres superior to the lateral ventricles).
   • Structure B: Frontal (anterior) horn of the lateral ventricle.
   • Structure C: Third ventricle (slit-like midline fluid-filled cavity situated between the thalami).
2. Site of Origin and Sonographic Landmarks:
   • Site: Subependymal germinal matrix at the caudothalamic groove (ganglionic eminence).
   • Key landmarks: Junction between the anterior head of the caudate nucleus and the anterior aspect of the thalamus, immediately inferior and lateral to the floor of the frontal horn of the lateral ventricle.
3. Predisposing Structural and Hemodynamic Attributes:
   • Abundant, fragile capillary network composed of a single endothelial layer lacking pericytic coverage and muscular basement membrane.
   • Immature cerebral autoregulation leading to pressure-passive cerebral circulation during fluctuations in arterial blood pressure or systemic venous congestion.
   • High local endogenous fibrinolytic activity due to increased tissue plasminogen activator (tPA) concentrations within the metabolically active germinal matrix.
4. Modified Papile Classification of IVH:
   • Grade I: Subependymal hemorrhage localized strictly to the germinal matrix without intraventricular rupture (or <10% intraventricular volume).
   • Grade II: Intraventricular hemorrhage occupying 10% to 50% of the lateral ventricular area without ventricular dilation.
   • Grade III: Intraventricular hemorrhage occupying >50% of the lateral ventricular area with acute lateral ventricular distension/dilation.
   • Grade IV (Periventricular Venous Infarction): Hemorrhage extending into adjacent periventricular white matter (secondary to impaired medullary venous drainage).
5. Posterior Fossa Acoustic Window:
   • Acoustic window: Mastoid fontanelle (posterolateral fontanelle) or posterolateral trans-mastoid view.
   • Plane: Coronal and axial-oblique planes through the petromastoid region to clearly delineate the cerebellar vermis, transverse cerebellar diameter, fourth ventricle, and cisterna magna.

1. Transducer Identification and Indications:
   • Probe 1 (Linear Array Transducer): High frequency (7.5–15 MHz). Flat footprint; generates a rectangular field. Indications: Vascular access (umbilical line or peripheral arterial line placement), lung ultrasound, superficial soft tissue, and cranial suture imaging.
   • Probe 2 (Curvilinear / Curved Array Transducer): Intermediate-to-high frequency (4–8 MHz). Curved footprint; wide sector field. Indications: Abdominal sonography, screening for necrotizing enterocolitis (portal venous gas, bowel wall thickening), and renal sonography.
   • Probe 3 (Phased Array Transducer): Small square footprint (5–8 MHz or 8–12 MHz neonatal micro-phased array). Beams originate from a single point to form a wide sector. Indications: Neonatal transthoracic echocardiography (capable of imaging through narrow intercostal spaces).
2. Probe Orientation Marker Convention:
   • Function: Establishes spatial orientation by correlating the physical probe edge with the on-screen index mark (usually a green dot or logo).
   • Echocardiographic Convention: By pediatric/adult cardiology convention, the screen index is positioned on the top right of the screen; the probe orientation marker is directed toward the patient's left shoulder (apical four-chamber view) or right shoulder/3 o'clock position (parasternal long-axis view).
3. Image Depth Optimization Rule:
   • The depth should be adjusted so that the target organ (the heart) occupies approximately two-thirds to three-quarters (65%–75%) of the total display screen, eliminating unnecessary far-field space to maximize frame rate and temporal resolution.
4. Physical Properties Comparison:
   • High-Frequency Transducers: Shorter acoustic wavelength, higher axial and lateral spatial resolution, but marked tissue attenuation and low depth penetration.
   • Low-Frequency Transducers: Longer acoustic wavelength, lower spatial resolution, but reduced tissue attenuation and superior depth penetration.

1. Identification of Lines:
   • Line A: Endotracheal tube (ETT).
   • Line B: Umbilical venous catheter (UVC).
   • Line C: Umbilical arterial catheter (UAC).
   • Line D: Nasogastric (NG) or orogastric tube.
2. Ideal Anatomic and Vertebral Terminations:
   • Line A (ETT): Mid-trachea, positioned between thoracic vertebrae T1 and T2 (or halfway between the inferior clavicular line and the carina, at least 1.0–1.5 cm above the carina).
   • Line B (UVC): Inferior vena cava (IVC) at the cavoatrial junction, positioned at vertebral levels T8–T9 (at or just above the level of the right hemidiaphragm).
   • Line C (UAC):
     • High placement (preferred): Thoracic aorta between T6 and T9 (above the celiac axis).
     • Low placement: Lumbar aorta between L3 and L5 (below the inferior mesenteric artery origin).
   • Line D (NG tube): Tip within the stomach lumen, passing at least 1–2 cm below the gastroesophageal junction (subdiaphragmatic) with the side-hole ports entirely inside the gastric bubble.
3. Vascular Trajectory of the UVC:
   • Umbilical vein $\rightarrow$ Left branch of portal vein $\rightarrow$ Ductus venosus $\rightarrow$ Middle/left hepatic vein $\rightarrow$ Inferior vena cava $\rightarrow$ Cavoatrial junction.
4. Malpositioned Line, Complications, and Management:
   • Malpositioned line: Line B (UVC) is positioned low, with its tip arrested in the intrahepatic portal system/ductus venosus (~T10–T11 level).
   • Complications: Hepatic parenchymal necrosis, intrahepatic hematoma, hepatic abscess, portal vein thrombosis, and long-term portal hypertension.
   • Immediate corrective action: Under sterile conditions, withdraw the catheter to convert it into a low emergency umbilical venous line (at 2–3 cm insertion depth, below the liver shadow) until alternative central venous access (e.g., PICC) is secured. Do not advance a previously placed catheter.

1. Radiographic Abnormality and Diagnosis:
   • Abnormality: Extensive, bilateral, symmetrical radiopaque calcifications distributed throughout the medullary pyramids of both kidneys outlining the renal papillae.
   • Diagnosis: Medullary nephrocalcinosis.
2. Differentiation from Nephrolithiasis:
   • Nephrocalcinosis: Diffuse deposition of calcium phosphate or calcium oxalate crystals within the renal parenchyma, predominantly localized to the medullary interstitium or tubular epithelium.
   • Nephrolithiasis: Organized macroscopic calculi situated within the pelvicalyceal collecting system, ureters, or urinary bladder.
3. Pathophysiology of Immobilization Hypercalciuria:
   • Complete lack of mechanical weight-bearing $\rightarrow$ Uncoupling of bone remodeling with increased osteoclastic bone resorption outstripping osteoblastic synthesis $\rightarrow$ Mobilization of skeletal calcium stores $\rightarrow$ Hypercalcemia and hypercalciuria $\rightarrow$ Exceeded renal solubility product of calcium phosphate/oxalate $\rightarrow$ Crystal nucleation, aggregation, and deposition within the renal medullary interstitium.
4. Other Pediatric Etiologies:
   • Hypercalcemic / Hypercalciuric states:
     • Primary hyperparathyroidism or Williams syndrome.
     • Chronic loop diuretic (furosemide) therapy in neonates.
     • Vitamin D intoxication.
   • Normocalcemic / Renal tubular states:
     • Distal (Type 1) Renal Tubular Acidosis (inability to acidify urine, hypocitraturia).
     • Primary hyperoxaluria (Types 1, 2, or 3).
     • Bartter syndrome.
     • Medullary sponge kidney.
5. Spot Urinary Calcium/Creatinine Ratio and Management:
   • Formula and Reference:
     $$ > \begin{aligned} > \text{Spot Urine } \frac{\text{Calcium}}{\text{Creatinine}} \text{ Ratio} &= \frac{\text{Urine Calcium (mg/dL)}}{\text{Urine Creatinine (mg/dL)}} \\ > \text{Normal Reference (>2 years)} &< \mathbf{0.20 \text{ mg/mg}} > \end{aligned} > $$
   • Conservative Medical Management:
     • Aggressive enteral hydration ($1.5–2.0 \times$ maintenance fluid requirement; $>2–3 \text{ L/m}^2/\text{day}$) to lower tubular crystal concentration.
     • Oral potassium citrate supplementation (1–2 mEq/kg/day divided BID/TID) to alkalinize urine and provide chelation of ionic calcium.
     • Thiazide diuretics (e.g., hydrochlorothiazide 1–2 mg/kg/day) to promote distal tubular calcium reabsorption.
     • Dietary sodium restriction to enhance proximal tubular calcium and sodium co-reabsorption.

1. Diagnosis and Etiology:
   • Diagnosis: Parenchymal Neurocysticercosis (NCC).
   • Causative Organism: Larval metacestode stage (Cysticercus cellulosae) of the human tapeworm Taenia solium.
2. Four Pathological / Radiological Stages:
   • Vesicular Stage: Viable cyst with transparent fluid and an intact, eccentric mural nodule (scolex). Minimal or no surrounding host inflammation; no perilesional edema; thin, non-enhancing or minimally enhancing wall.
   • Colloidal Vesicular Stage: Larval degeneration. Cyst fluid becomes turbid; thick fibrous wall with intense perilesional host inflammatory reaction, marked vasogenic edema, and ring-enhancement on contrast CT/T1-post-gadolinium MRI.
   • Granular Nodular Stage: Retraction and collapse of cyst cavity replaced by lymphoid/granulomatous tissue; thick nodular ring or disc enhancement with persistent but decreasing edema.
   • Calcified Nodular Stage: Involuted, end-stage, mineralized lesion; small, dense hyperdense nodule on non-contrast CT (signal drop-out blooming on MRI GRE/SWI) without surrounding edema or contrast enhancement.
3. Pathognomonic Sign:
   • "Hole-with-a-dot" sign: A rounded CSF-isodense/isointense cystic cavity containing a hyperdense/hypointense eccentric 1–2 mm mural nodule representing the invaginated scolex.
4. Pharmacotherapeutic Management Protocol:
   • Antihelminthic Regimen:
     • Albendazole: 15 mg/kg/day orally divided into two daily doses (taken with meals, maximum 800 mg/day) for 14 days (or 8–14 days for single enhancing lesions; 10–14 days for multiple lesions).
     • Dual therapy for >2 viable cysts: Add Praziquantel: 50 mg/kg/day orally divided TID for 10–14 days.
   • Adjunctive Corticosteroid Therapy (Mandatory):
     • Prednisolone 1–2 mg/kg/day orally (or Dexamethasone 0.1–0.15 mg/kg/day) initiated 1 to 2 days prior to starting the antihelminthic agent, continued throughout therapy, and tapered over the subsequent 1 to 2 weeks to suppress host neuroinflammation triggered by parasite lysis.
   • Antiseizure Medication (ASM):
     • First-line monotherapy with carbamazepine (10–20 mg/kg/day), oxcarbazepine (15–30 mg/kg/day), or levetiracetam (20–40 mg/kg/day). Maintained until resolution of active inflammation on neuroimaging and seizure freedom for 6–12 months.
5. Mandatory Baseline Pre-treatment Screening:
   • Funduscopic / Ophthalmic Examination (and ocular B-scan ultrasonography if fundus obscured):
   • Rationale: To rule out concurrent intraocular or intraretinal cysticerci. Cysticidal therapy in the presence of ocular cysticercosis can provoke acute retinal inflammation, vitritis, detachment, and irreversible blindness.

1. Neuroimaging Findings:
   • Marked, symmetrical ballooning/dilatation of both lateral ventricles (severe ventriculomegaly) and the third ventricle.
   • Normal-sized, non-dilated, midline fourth ventricle.
   • Periventricular hypoattenuation (transependymal transudation/edema) surrounding the frontal and occipital horns.
   • Effacement of cerebral sulci and cortical thinning from raised intracranial pressure.
2. Radiological Diagnosis & Level of Obstruction:
   • Diagnosis: Obstructive (non-communicating) hydrocephalus.
   • Site of Obstruction: Cerebral Aqueduct of Sylvius (midbrain junction between third and fourth ventricles).
3. Etiologies:
   • Congenital (any 3):
     • Congenital aqueductal stenosis (aqueductal gliosis, forking, or septum/web formation).
     • X-linked hydrocephalus (L1CAM gene mutation; Bickers-Adams-Edwards syndrome).
     • Chiari II malformation (with myelomeningocele).
     • Dandy-Walker malformation complex.
     • Intrauterine infections (TORCH, particularly congenital Toxoplasmosis or CMV).
   • Acquired (any 2):
     • Post-infectious ependymitis/gliosis (post-bacterial or tuberculous meningitis).
     • Post-hemorrhagic ventricular obstruction (following neonatal intraventricular hemorrhage).
     • Tectal plate or pineal region neoplasms (tectal glioma, pineoblastoma, germinoma).
4. Surgical Management:
   • Endoscopic Third Ventriculostomy (ETV): Creation of a perforation in the floor of the third ventricle (tuber cinereum/premammillary recess) into the interpeduncular cistern; often combined with choroid plexus cauterization (ETV/CPC).
   • Contraindications to ETV: Obliterated prepontine/interpeduncular subarachnoid cisterns, active ventriculitis/meningitis, thick scarred arachnoid membranes, age <6 months (relative contraindication with lower success rates), anatomy obscuring the floor of the third ventricle (basilar artery displacement).
   • Alternative / Shunt Procedure: Ventriculoperitoneal (VP) shunt placement (medium- or programmable-pressure valve).

graph TD
    A[Progressive Macrocephaly / Raised ICP] --> B[Non-Contrast Cranial CT / MRI Brain]
    B --> C[Triventricular Hydrocephalus: Dilated Lateral & 3rd Ventricles; Normal 4th Ventricle]
    C --> D[Diagnosis: Obstructive Hydrocephalus at Sylvian Aqueduct]
    D --> E{Age & Basal Cistern Anatomy?}
    E -->|Clear prepontine cistern & Age > 6 mo| F[Endoscopic Third Ventriculostomy +/- CPC]
    E -->|Scarred cisterns / Prior hemorrhage / Failed ETV| G[Ventriculoperitoneal Shunt Placement]

1. Radiological Findings:
   • Diffuse, homogeneous, symmetric osteosclerosis ("chalky", "marble bone" appearance) involving cortex and medullary cavity.
   • Loss of normal corticomedullary differentiation.
   • "Bone-in-bone" appearance (endobone) within the vertebrae, iliac wings, and phalanges.
   • "Sandwich vertebrae" (dense sclerotic bands along superior and inferior endplates with a radiolucent central band).
   • Metaphyseal splaying ("Erlenmeyer flask" deformity) of distal femora and proximal tibiae.
2. Diagnosis and Pathophysiological Defect:
   • Diagnosis: Infantile Malignant (Autosomal Recessive) Osteopetrosis (Albers-Schönberg disease).
   • Defect: Failure of osteoclast-mediated bone resorption due to defective osteoclast proton pump or chloride channel. Most commonly caused by mutations in TCIRG1 (encodes osteoclast-specific vacuolar $H^+$-ATPase subunit a3), CLCN7 (chloride voltage-gated channel 7), or OSTM1.
3. Radiological Differentials:
   • Pyknodysostosis.
   • Osteopathia striata.
   • Camurati-Engelmann disease (Progressive diaphyseal dysplasia).
   • Chronic fluoride/lead intoxication (heavy metal sclerosis).
4. Differences from Pyknodysostosis:
   • Clinical:
     • Osteopetrosis: Severe early infantile bone marrow failure (leucoerythroblastosis, cytopenias), massive hepatosplenomegaly (extramedullary hematopoiesis), cranial nerve palsies/optic atrophy, poor prognosis if untreated.
     • Pyknodysostosis: Normal bone marrow function/no hematological failure, normal lifespan/good prognosis, severe disproportionate dwarfism, delayed fontanelle closure, hypoplastic distal digits (acro-osteolysis).
   • Radiological:
     • Osteopetrosis: "Bone-in-bone" appearance, "sandwich" vertebrae, narrow neural foramina, absent acro-osteolysis.
     • Pyknodysostosis: Acro-osteolysis (resorption of distal clavicles and terminal phalanges), persistent wide/open cranial sutures/fontanelles, wormian bones, hypoplastic micrognathic mandible with loss of mandibular angle.
5. Management:
   • Definitive Cure: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) prior to irreversible optic nerve damage (provides functional donor osteoclasts derived from monocyte-macrophage lineage).
   • Medical Bridging / Adjunctive Therapy:
     • Calcitriol (high-dose 1,25-dihydroxycholecalciferol) to stimulate dormant osteoclasts.
     • Recombinant Interferon gamma-1b ($1.5\ \mu\text{g/kg}$ subcutaneously 3 times/week).
     • Corticosteroids (Prednisolone $1\text{--}2\ \text{mg/kg/day}$) to treat anemia and promote bone resorption.
     • Packed RBC and platelet transfusions for cytopenias.

1. Neurosonographic Findings:
   • Multiple, well-defined, discrete bilateral, symmetric cystic lucencies in the deep periventricular white matter.
   • Cysts localized predominantly dorsolateral to the lateral ventricles (centra semiovale, optic radiation, and parietal-occipital periventricular regions).
   • Secondary mild ex-vacuo ventricular enlargement with irregular ventricular contours.
2. Diagnosis and Severity Classification:
   • Diagnosis: Cystic Periventricular Leukomalacia (cPVL).
   • Classification (de Vries Grading):
     • Grade 1: Transient periventricular hyper-echogenicity persisting $\ge 7$ days.
     • Grade 2: Periventricular echogenicity evolving into small localized periventricular fronto-parietal cysts.
     • Grade 3: Extensive periventricular cystic lesions in fronto-parieto-occipital white matter.
     • Grade 4: Extensive cystic lesions involving deep periventricular white matter extending into subcortical white matter.
     • Assignment: Grade 3 PVL (if confined to fronto-parieto-occipital periventricular white matter) or Grade 4 PVL (if extending into subcortical white matter).
3. Pathophysiological Vulnerability:
   • Vascular/Anatomical Factors:
     • Vascular Watershed Zone: Periventricular white matter lies in the boundary zones between ventriculopetal (centripetal) and ventriculofugal (centrifugal) arteries, which have poor anastomoses.
     • Impaired Cerebrovascular Autoregulation: Immature preterm cerebral vasculature exhibits "pressure-passive" cerebral circulation, rendering periventricular tissue ischemic during systemic hypotension.
   • Cellular Factors:
     • Pre-Oligodendrocyte (pre-OL) Vulnerability: Developing early oligodendrocytes ($O4^+/O1^-$ late progenitors) are exquisitely sensitive to reactive oxygen/nitrogen species and glutamate excitotoxicity.
     • Maternal-Fetal Infection / Inflammation: Release of maternal and fetal pro-inflammatory cytokines (IL-1$\beta$, TNF-$\alpha$, IL-6) and microglial activation directly triggers apoptotic pathways in developing pre-OLs.
4. Anticipated Long-Term Neurodevelopmental Sequelae:
   • Motor Sequelae: Spastic Cerebral Palsy—predominantly Spastic Diplegia (because corticospinal tracts for lower extremities run closest to the ventricular walls) or Spastic Quadriplegia (if lesions extend laterally into arm/trunk fibers).
   • Visual Sequelae: Cerebral/Cortical Visual Impairment (CVI) due to damage to the optic radiations (geniculocalcarine tract) in the periventricular trigone; strabismus and visual field defects.
   • Cognitive / Sensory: Executive dysfunction, learning disabilities, and sensorineural processing abnormalities.

1. Diagnosis and Radiographic Signs:
   • Diagnosis: Pneumomediastinum (Mediastinal Emphysema).
   • Radiographic Signs (any 3):
     • Spinnaker-sail sign (Angel wing sign): Thymus elevated and displaced laterally and superiorly by mediastinal air.
     • Continuous diaphragm sign: Free air trapped between the pericardium and the diaphragm allowing visualization of the entire diaphragm across the midline.
     • Pneumopericardium stripe / Double bronchial wall sign: Radiolucent linear gas outlining mediastinal structures, aorta, or trachea.
     • Ring-around-the-artery sign: Air surrounding the main pulmonary artery or thoracic aorta.
     • Subcutaneous emphysema: Radiolucent streaks within the soft tissues of the neck and chest wall.
2. Pathophysiology (The Macklin Effect):
   • Severe coughing or bronchospasm produces high intra-alveolar pressures against a closed or obstructed airway.
   • Alveolar pressure exceeds perivascular interstitial pressure, leading to terminal alveolar rupture.
   • Air dissects along the peribronchovascular sheaths (bronchovascular bundles) toward the hilum and directly into the mediastinal space.
3. Eponymous Auscultatory Sign:
   • Hamman's Sign (Hamman's Crunch).
   • How elicited: Precordial systolic-synchronous crunching, rasping, or clicking sounds heard loudest over the apex and left sternal border; classically accentuated during ventricular systole and when the patient is placed in the left lateral decubitus position in end-expiration.
4. Management & Indications for Advanced Imaging:
   • Management Protocol:
     • Supplemental high-concentration oxygen therapy ($FiO_2\ 0.60\text{--}1.00$ via non-rebreather mask) to promote nitrogen washout ("nitrogen de-nitrogination"), which accelerates reabsorption of free mediastinal air.
     • Aggressive treatment of underlying status asthmaticus: Inhaled short-acting $\beta_2$-agonists (Salbutamol $2.5\text{--}5.0\ \text{mg}$ nebulized), inhaled Ipratropium bromide, and systemic corticosteroids (Methylprednisolone $1\text{--}2\ \text{mg/kg/day}$ or Dexamethasone $0.6\ \text{mg/kg/dose}$).
     • Rest, analgesia, and avoidance of positive-pressure maneuvers/Valsalva.
   • Red-Flag Complications: Tension pneumomediastinum (causing venous compression and obstructive shock), concurrent tension pneumothorax, and tracheal compression.
   • Indications for CT / Esophagogram: History of blunt/penetrating chest trauma, forceful vomiting preceded by chest pain (suspected Boerhaave syndrome/esophageal perforation), foreign body ingestion, fever, septic presentation, or failure to improve with conservative therapy.

1. Diagnosis and Differentiating Feature:
   • Diagnosis: Pneumopericardium (Tension Pneumopericardium).
   • Differentiating Feature: In pneumopericardium, gas completely encircles the cardiac contour (including the inferior/diaphragmatic surface) and is strictly confined within the pericardial reflection, stopping abruptly below the level of the reflection over the great vessels (does not extend into the superior mediastinum or neck tissues). In contrast, pneumomediastinum air extends above the great vessels into the superior mediastinum, thoracic inlet, and neck.
2. Bedside Diagnostic Modalities:
   • Point-of-Care Echocardiography (POCUS): Direct visualization of pericardial air artifact (air-gap sign with inability to visualize cardiac structures subcostally) and compressed cardiac ventricles.
   • Cold-light Chest Transillumination: Shows localized precordial halo illumination directly over the sternum.
   • Electrocardiogram (ECG): Marked low-voltage QRS complexes in all limb and precordial leads with ST-T changes.
3. Tension vs. Non-Tension & Emergency Procedure:
   • Tension vs Non-Tension: Non-tension pneumopericardium is asymptomatic without hemodynamic impairment; tension pneumopericardium presents with acute cardiac tamponade (obstructive shock, refractory hypotension, severe bradycardia, compressed small cardiac silhouette "halo sign").
   • Emergency Decompression (Needle Pericardiocentesis):
     • Needle Site: Subxiphoid approach (just below the xiphoid process, between xiphoid and left costal margin).
     • Direction/Trajectory: 20- to 22-gauge angiocatheter directed at a $30^\circ\text{--}45^\circ$ angle to the skin surface, aimed towards the left mid-clavicle/left shoulder while maintaining continuous negative aspiration.
4. Ventilator Modifications:
   • Transition to High-Frequency Oscillatory Ventilation (HFOV) or High-Frequency Jet Ventilation (HFJV) to deliver tidal volumes smaller than anatomical dead space.
   • If remaining on conventional ventilation: Reduce Peak Inspiratory Pressure (PIP), reduce Positive End-Expiratory Pressure (PEEP $\le 4\text{--}5\ \text{cmH}_2\text{O}$), and shorten inspiratory time ($Ti \le 0.3\ \text{s}$) to avoid dynamic hyperinflation.
   • Accept permissive hypercapnia ($pCO_2\ 50\text{--}65\ \text{mmHg}$ with $\text{pH} \ge 7.22$).

1. Primary Diagnosis and Radiographic Signs:
   • Diagnosis: Massive pneumoperitoneum secondary to gastrointestinal perforation.
   • Classic signs on supine film:
     • Football sign: Large, oval/elliptical radiolucency over the central abdomen resembling an American football.
     • Rigler sign (double-wall sign): Visualization of both the inner (luminal) and outer (serosal) margins of the bowel wall outlined by gas.
     • Falciform ligament sign (Silver sign): Oblong linear soft-tissue density running vertically in the right upper quadrant outlined on both sides by free intraperitoneal gas.
     • Continuous diaphragm sign: Free air under the central tendon of the diaphragm allowing continuous visualization of the diaphragmatic dome across the midline.
2. Anatomical and Physical Basis:
   • Rigler Sign: Normally, only the intraluminal gas-mucosa interface is visible because the outer serosa abuts peritoneal fluid or adjacent soft-tissue structures of equal radiodensity. When free air enters the peritoneal cavity, it surrounds the outer serosal surface, creating radiographic contrast on both sides of the bowel wall.
   • Falciform Ligament Sign: The falciform ligament normally blends imperceptibly with adjacent peritoneal fat and liver parenchyma. When surrounded bilaterally by large amounts of free peritoneal gas, the soft-tissue density of the ligament is sharply outlined in relief.
3. Alternative Radiographic Projections:
   • Left Lateral Decubitus (Horizontal Beam): Patient placed on the left side for at least 10–15 minutes prior to exposure; free air rises and layers between the lateral margin of the liver and the right abdominal lateral wall (avoids confusion with gastric fundic bubble).
   • Cross-Table (Shoot-Through) Lateral View: Patient maintained supine with a horizontal beam directed across the abdomen; free air collects immediately beneath the anterior abdominal wall.
4. Emergency Medical Stabilization Protocol:
   • Airway and Breathing: High-flow oxygen via non-rebreather mask; endotracheal intubation if respiratory failure ensues due to diaphragmatic splinting.
   • Decompression: Placement of a wide-bore (8–10 Fr) orogastric/nasogastric tube on continuous low suction to decompress the stomach and minimize continuing air leakage.
   • Fluid Resuscitation: Rapid intravenous crystalloid bolus (Normal Saline 0.9% or Ringer's Lactate) at $20\text{ mL/kg}$ over 15–20 minutes, repeated as necessary to restore perfusion and blood pressure.
   • Empirical Broad-Spectrum Intravenous Antibiotics:
     • Ampicillin: $50\text{ mg/kg/dose}$ IV every 6 hours, PLUS
     • Gentamicin: $7.5\text{ mg/kg/dose}$ IV once daily (or Amikacin $15\text{ mg/kg/day}$ IV divided q12h), PLUS
     • Metronidazole: $10\text{ mg/kg/dose}$ IV every 8 hours (or Piperacillin-Tazobactam monotherapy: $100\text{ mg/kg/dose}$ of piperacillin component IV every 6–8 hours).

1. Diagnosis and Ultrasonographic Findings:
   • Diagnosis: Post-Hemorrhagic Ventricular Dilatation (PHVD) secondary to severe intraventricular hemorrhage.
   • Coronal view: Symmetrical rounding and ballooning of both frontal horns with loss of the normal slit-like configuration, ventricular enlargement crossing the 97th percentile, blunting of the superolateral angles.
   • Parasagittal view: Dilatation of the entire lateral ventricle (frontal horn, body, occipital horn, temporal horn), thick/hyperechoic ependymal lining reflecting chemical ventriculitis, and mobile or resolving intraventricular echogenic thrombi/clots.
2. Diagnostic Indices and Intervention Thresholds:
   • Ventricular Index (Levene): Absolute horizontal distance (in millimeters) from the midline falx cerebri to the most lateral wall of the anterior horn of the lateral ventricle on a coronal scan at the level of the foramen of Monro.
   • Anterior Horn Width (AHW): Diagonal width across the lumen of the anterior horn at its widest point on a coronal view at the level of the foramen of Monro (normal $<3\text{ mm}$).
   • Active Intervention Threshold (ELVIS Trial Criteria):
     • Low threshold / Action line: Ventricular Index $>97\text{th}\text{ percentile} + 4\text{ mm}$ and/or AHW $>6\text{ mm}$ with Thalamo-Occipital Distance (TOD) $>24\text{ mm}$.
3. Ventricular-to-Hemispheric Ratio Calculation:
   $$ > \begin{aligned} > \text{VHR} &= \frac{\text{Ventricular Width (Falx to Lateral Wall)}}{\text{Hemispheric Width (Falx to Inner Skull Table)}} \\ > &= \frac{24\text{ mm}}{48\text{ mm}} \\ > &= \mathbf{0.50} \quad (\text{Normal reference: } \le 0.35) > \end{aligned} > $$
4. Temporizing and Definitive Management:
   • Temporizing Management:
     • Serial Lumbar Punctures (if communicating hydrocephalus documented): $10\text{ to } 15\text{ mL/kg}$ CSF drained daily or alternate days to keep VI $<97\text{th}\text{ percentile} + 4\text{ mm}$.
     • Ventricular Reservoir (Ommaya or Rickham reservoir) or Ventricular Subgaleal Shunt (VSGS): Indicated when non-communicating or lumbar punctures fail; permits sterile percutaneous CSF aspiration ($10\text{ to } 15\text{ mL/kg/day}$).
     • Note: Medical therapy with acetazolamide and furosemide is contraindicated due to increased nephrocalcinosis and worse neurologic outcomes without reducing need for shunt.
   • Definitive Neurosurgical Intervention:
     • Ventriculoperitoneal (VP) Shunt placement once the infant reaches $>2.0\text{ to } 2.5\text{ kg}$, CSF protein decreases to $<1.5\text{ g/L}$, and CSF is free of blood/infection.
     • Neuro-endoscopic third ventriculostomy with choroid plexus cauterization (ETV/CPC) in selected centers.

1. Neuroimaging Diagnosis and Secondary Pathogenesis:
   • Diagnosis: Post-meningitic hydrocephalus (severe ventriculomegaly with periventricular transependymal CSF transudation / interstitial edema).
   • Pathogenesis: Neonatal bacterial meningitis induces severe subarachnoid and leptomeningeal inflammation, leading to extensive arachnoid fibrosis, obliteration of arachnoid villi, and exudative obstruction of basal cisterns.
2. Mechanistic Distinction:
   • Communicating (Extraventricular Obstructive): Most common form post-meningitis. CSF flows freely through the ventricular system (lateral, third, and fourth ventricles and exits fourth ventricle foramina of Luschka and Magendie), but resorption is impaired at the fibrosed arachnoid granulations and thickened basal cisterns.
   • Non-communicating (Intraventricular Obstructive): Inflammatory debris, ventriculitis, and ependymal scarring cause direct mechanical stenosis within the ventricular pathways, most commonly at the Aqueduct of Sylvius or the Foramen of Monro.
3. Evans' Index Calculation and Interpretation:
   $$ > \begin{aligned} > \text{Evans' Index} &= \frac{\text{Maximum transverse diameter of frontal horns}}{\text{Maximum internal biparietal diameter (inner skull table)}} \\ > &= \frac{46\text{ mm}}{92\text{ mm}} \\ > &= \mathbf{0.50} > \end{aligned} > $$
   • Interpretation: Normal Evans' Index is $<0.30$. A value of $0.50$ confirms marked pathological ventricular dilatation.
4. Medical Protocol for Temporizing CSF Reduction:
   • Acetazolamide:
     • Mechanism: Carbonic anhydrase inhibitor in the choroid plexus; reduces choroid plexus epithelial CSF production.
     • Dose: $25\text{ mg/kg/day}$ orally divided every 8 hours, titrated gradually up to a maximum of $100\text{ mg/kg/day}$ (monitored closely for hyperchloremic metabolic acidosis and electrolyte imbalance).
   • Furosemide (adjunct):
     • Mechanism: Loop diuretic that inhibits sodium-potassium-chloride cotransport and reduces choroid plexus water transport.
     • Dose: $1\text{ mg/kg/day}$ orally or intravenously divided every 12 hours.
   • Definitive Plan: Urgent neurosurgical consultation for Ventriculoperitoneal (VP) Shunt or Endoscopic Third Ventriculostomy (ETV).

1. Neuroimaging Findings and Diagnosis:
   • Imaging findings: Symmetrical, patchy hyperintensities on T2-weighted and Fluid-Attenuated Inversion Recovery (FLAIR) sequences, predominantly involving the cortical and subcortical white matter of the parieto-occipital lobes, sparing the calcarine and paramedian occipital cortices. Apparent Diffusion Coefficient (ADC) mapping shows hyperintensity (elevated diffusion) consistent with vasogenic (not cytotoxic) edema.
   • Diagnosis: Posterior Reversible Encephalopathy Syndrome (PRES) secondary to acute post-streptococcal glomerulonephritis (APSGN).
2. Differential Diagnoses on Neuroimaging:
   • Acute ischemic stroke involving bilateral posterior cerebral arteries / basilar artery occlusion (demonstrates restricted diffusion on DWI with low ADC due to cytotoxic edema).
   • Cerebral venous sinus thrombosis (CVST) with venous infarction.
   • Acute viral or autoimmune encephalitis (e.g., anti-NMDAR, HSV).
   • Acute Disseminated Encephalomyelitis (ADEM).
   • Hypoglycemic brain injury or mitochondrial encephalopathy (MELAS).
3. Pathophysiological Mechanisms:
   • Cerebral Hyperperfusion Hypothesis (Autoregulatory Breakdown): Sudden severe elevation in blood pressure overcomes the myogenic autoregulatory limits of the cerebral vasculature (mean arterial pressure $>150\text{ mmHg}$). Because the posterior circulation (vertebrobasilar system) has significantly sparser sympathetic adrenergic innervation compared to the carotid circulation, autoregulatory breakthrough occurs preferentially in the parieto-occipital regions, leading to passive vasodilation, fluid extravasation, and vasogenic edema.
   • Endothelial Dysfunction Hypothesis: Circulating cytokines, immune complexes, or toxins cause systemic endothelial activation and injury, altering the blood-brain barrier permeability and triggering fluid transudation even at moderately elevated blood pressures.
4. Emergency Management Protocol:
   • Rate of Blood Pressure Lowering:
     • Reduce Mean Arterial Pressure (MAP) by no more than $20\text{ to } 25\%$ over the first 2–4 hours, then gradually lower toward the 95th percentile over the subsequent 24–48 hours (to prevent cerebral, optic nerve, and renal hypoperfusion).
   • First-Line Intravenous Antihypertensive:
     • Labetalol: IV bolus $0.2\text{ to } 0.5\text{ mg/kg}$ (max $20\text{ mg}$) over 2–5 minutes; if ineffective, initiate continuous infusion at $0.25\text{ to } 3.0\text{ mg/kg/hour}$, OR
     • Nicardipine: Continuous IV infusion starting at $0.5\text{ to } 1.0\text{ mcg/kg/min}$, titrated every 15–30 minutes up to maximum $4.0\text{ to } 5.0\text{ mcg/kg/min}$.
   • Acute Seizure Termination:
     • Lorazepam: $0.1\text{ mg/kg}$ IV (max $4\text{ mg}$) administered over 2 minutes; followed by Levetiracetam $40\text{ to } 60\text{ mg/kg}$ IV over 10 minutes for seizure prophylaxis.

1. Cardinal Radiographic Signs:
   • Homogeneous complete opacification of the entire right hemithorax.
   • Marked ipsilateral mediastinal shift (heart, trachea, and mediastinal structures completely displaced into the affected right hemithorax; in a large effusion, the mediastinum is pushed to the contralateral side).
   • Compensatory herniation and hyperinflation of the contralateral (left) lung across the midline into the right upper chest.
   • Ipsilateral crowding of ribs with narrowing of intercostal spaces and elevation of the right hemidiaphragm.
2. Diagnosis and Boyden Classification:
   • Diagnosis: Right unilateral pulmonary agenesis.
   • Boyden Classification:
     • Type 1 (Agenesis): Complete absence of lung parenchyma, carina, main bronchus, and pulmonary vasculature (pulmonary artery).
     • Type 2 (Aplasia): Rudimentary blind-ending bronchus present; complete absence of pulmonary parenchyma and pulmonary vessels.
     • Type 3 (Hypoplasia): Hypoplastic bronchus, rudimentary parenchymal tissue, and variable hypoplastic vasculature present.
3. Associated Congenital Anomalies (VACTERL / Associated Syndromes):
   • Cardiovascular anomalies (50%): Tetralogy of Fallot, patent ductus arteriosus, ventricular septal defect, anomalous pulmonary venous return.
   • Tracheoesophageal malformations: Tracheoesophageal fistula (TEF) or esophageal atresia.
   • Vertebral and skeletal malformations: Hemivertebrae, scoliosis, radial ray anomalies.
   • Anorectal and genitourinary malformations: Imperforate anus, unilateral renal agenesis, horseshoe kidney.
4. Confirmatory Imaging and Pathognomonic Distinction:
   • Investigation of Choice: High-Resolution Contrast-Enhanced Computed Tomography (CECT) of the chest with CT Angiography (or Bronchoscopy combined with Echocardiography).
   • Distinction from Total Atelectasis:
     • Pulmonary agenesis: Complete absence of the right main bronchus branching from the trachea (or rudimentary stump in aplasia) AND complete absence of the right pulmonary artery branching from the main pulmonary trunk.
     • Total atelectasis: Patent mainstem bronchus leading into fully present, collapsed pulmonary parenchymal architecture containing an intact pulmonary arterial and venous tree.

1. Radiographic Findings:
   • Massive, symmetric globular enlargement of the cardiac silhouette ("water-bottle" or flask-shaped contour) with loss of normal cardiac waist and border indentations.
   • Obtuse cardiophrenic angles bilaterally.
   • Left-sided intercostal drainage tube in situ with resolving/residual parenchymal consolidation.
2. Diagnosis & Triad:
   • Diagnosis: Purulent pericardial effusion (pyopericardium) complicated by cardiac tamponade.
   • Clinical Triad: Beck's triad (hypotension, distant/muffled heart sounds, and elevated jugular venous pressure).
3. Immediate Procedure:
   • Procedure: Emergent bedside pericardiocentesis with drainage catheter placement under real-time point-of-care ultrasound (POCUS) guidance.
   • Anatomical Approach: Subxiphoid approach (needle inserted between xiphoid process and left costal margin at a 30–45° angle to the skin, directed toward the left shoulder while continuously aspirating).
4. Definitive Management & Dosing:
   • Surgical: Subxiphoid pericardial window, video-assisted thoracoscopic surgery (VATS) pericardiectomy, or formal anterior pericardiectomy with continuous drainage to prevent reaccumulation and constrictive pericarditis.
   • Intravenous Antibiotics:
     • Inj. Vancomycin: 15 mg/kg/dose IV every 6 hours (60 mg/kg/day; 225 mg IV q6h) to cover Methicillin-resistant Staphylococcus aureus (MRSA).
     • Inj. Ceftriaxone: 100 mg/kg/day IV once daily or divided q12h (1500 mg/day) OR Inj. Piperacillin-Tazobactam: 100 mg/kg/dose IV every 6 hours (1.5 g IV q6h) to cover associated gram-negative pathogens. Duration: 3 to 4 weeks parenterally.

1. Radiological Abnormalities:
   • Cupping: Concavity of the distal metaphyses of the radius and ulna instead of the normal flat or convex contour.
   • Fraying: Irregular, frayed, thread-like brush border margin along the metaphyseal-epiphyseal junction.
   • Widening / Splaying: Lateral spreading/flaring of the distal metaphysis.
   • Increased radiolucent gap: Widening of the radiolucent space between the distal metaphyseal margin and the carpal ossification centers.
   • Generalized osteopenia: Cortical thinning and coarse trabecular pattern of the radial and ulnar shafts.
2. Earliest Sign of Healing:
   • Appearance of a dense, white transverse line across the distal metaphysis representing the re-establishment of the provisional zone of calcification (typically within 2 to 3 weeks of starting therapy).
3. Confirmatory Biochemical Profile (Nutritional Vitamin D Deficiency Rickets):
   • Serum 25-hydroxyvitamin D [25(OH)D]: Low (< 12 ng/mL or < 30 nmol/L).
   • Serum Alkaline Phosphatase (ALP): Markedly elevated (> 500–1000 IU/L).
   • Serum Inorganic Phosphorus: Low to low-normal (< 4.0 mg/dL).
   • Serum Calcium: Normal to low (secondary to secondary hyperparathyroidism).
   • Serum Intact Parathyroid Hormone (iPTH): Markedly elevated (secondary hyperparathyroidism).
   • Urine Calcium-to-Creatinine ratio: Reduced (< 0.1 mg/mg) with elevated urinary phosphate excretion (reduced tubular reabsorption of phosphate, TRP < 85%).
4. Pharmacological Management:
   • Vitamin D (Cholecalciferol):
     • Stoss therapy: 300,000 to 600,000 IU orally as a single dose or divided over 2 to 4 doses; OR
     • Daily therapy: 2,000 to 5,000 IU/day orally for 8 to 12 weeks.
     • Maintenance: Followed by 400–600 IU/day orally.
   • Elemental Calcium:
     • 30–50 mg/kg/day orally (divided in 2–3 doses) for 8 to 12 weeks alongside vitamin D to prevent "hungry bone syndrome" hypocalcemia.

1. Radiographic Findings & Criteria:
   • Finding: Marked widening of the prevertebral / retropharyngeal soft-tissue space with loss/reversal of normal cervical lordosis and anterior displacement and compression of the pharyngeal airway column.
   • Diagnostic Criteria on True Lateral Cervical X-ray (in inspiration/extension):
     • At C2: Retropharyngeal soft-tissue thickness > 7 mm (or > 1/3 to 1/2 the width of the adjacent C2 vertebral body).
     • At C6: Retrotracheal soft-tissue thickness > 14 mm in children < 15 years (or > adjacent vertebral body width).
2. Definitive Imaging & Differentiation:
   • Modality: Contrast-enhanced computed tomography (CECT) of the neck and upper chest.
   • Differentiation:
     • Abscess: Well-defined hypodense non-enhancing fluid collection with rim/peripheral enhancement and internal gas bubbles or scalloping of the wall.
     • Phlegmon/Cellulitis: Diffuse soft-tissue thickening and inflammatory infiltration with non-rim-enhancing or uniform contrast enhancement, without a liquefactive central core.
3. Life-Threatening Complications:
   • Acute upper airway obstruction and asphyxia.
   • Spontaneous rupture with purulent aspiration leading to severe aspiration pneumonia, lung abscess, or acute respiratory distress syndrome (ARDS).
   • Descending mediastinitis via the "danger space" (posterior to retrovisceral space) into the posterior mediastinum.
   • Thrombophlebitis of the internal jugular vein (Lemierre syndrome).
   • Erosion or pseudoaneurysm of the internal carotid artery.
4. Management:
   • Empirical Intravenous Antibiotics (covering Streptococcus pyogenes, Staphylococcus aureus, and oral anaerobes):
     • Inj. Ampicillin-Sulbactam: 50 mg/kg/dose IV every 6 hours (200 mg/kg/day of ampicillin component); OR
     • Inj. Ceftriaxone (100 mg/kg/day IV divided q12h) PLUS Inj. Clindamycin (10 mg/kg/dose IV every 8 hours, 30 mg/kg/day); OR Inj. Vancomycin if MRSA suspected.
   • Surgical Drainage: Urgent intraoral incision and drainage (or external transcervical approach if extending laterally) indicated if there is evidence of airway compromise, mature fluid collection on CECT > 2 cm in diameter, or failure of clinical improvement after 24–48 hours of parenteral antibiotic therapy.

1. Measurement Method (Cobb Angle Method):
   • Identify the superior end-vertebra: The uppermost vertebra in the curve whose superior endplate tilts maximally toward the concavity of the curve.
   • Identify the inferior end-vertebra: The lowermost vertebra in the curve whose inferior endplate tilts maximally toward the concavity of the curve.
   • Draw a line along the superior endplate of the superior end-vertebra and another line along the inferior endplate of the inferior end-vertebra.
   • Construct perpendicular lines to these endplate lines; the angle at their intersection is the Cobb angle.
2. Diagnostic Threshold:
   • A Cobb angle of $\mathbf{> 10^\circ}$ in the coronal plane on a standing radiograph, accompanied by vertebral rotation.
3. Clinical Thresholds:
   • Cardiopulmonary Compromise: Curves reaching $\mathbf{\ge 80^\circ - 90^\circ}$ (leads to restrictive lung defect, alveolar hypoventilation, pulmonary hypertension, and cor pulmonale).
   • Orthosis / Bracing Indication: Cobb angle between $\mathbf{25^\circ \text{ and } 40^\circ}$ in a skeletally immature patient (Risser grade 0–2).
   • Surgical Correction / Fusion: Cobb angle $\mathbf{\ge 45^\circ - 50^\circ}$ in growing children or curves refractory to brace therapy.
4. Risser Grading System:
   • Assesses the extent of ossification of the iliac apophysis from anterolateral to posteromedial (divided into four quarters):
     • Grade 0: No ossification center visible (maximum skeletal immaturity; highest progression risk).
     • Grade 1: Ossification over the anterior 25% of the iliac apophysis.
     • Grade 2: Ossification extending to 26–50%.
     • Grade 3: Ossification extending to 51–75%.
     • Grade 4: Complete ossification across 76–100% without fusion.
     • Grade 5: Complete bony fusion of the apophysis to the iliac crest (skeletal maturity achieved).

1. Radiological Findings:
   • Bilateral, symmetric, perihilar fluffy non-homogenous alveolar opacities with central distribution and peripheral sparing ("bat-wing" or "butterfly" pattern).
   • Prominent interstitial markings, peribronchial cuffing, and mild cardiomegaly consistent with acute pulmonary edema.
2. Diagnosis & Causative Agent:
   • Diagnosis: Acute non-cardiogenic / cardiogenic pulmonary edema secondary to severe scorpion sting envenomation.
   • Causative Organism: Mesobuthus tamulus (Indian red scorpion).
3. Pathophysiology:
   • Scorpion alpha-toxin delays the inactivation of neuronal voltage-gated sodium channels, causing repetitive firing and sustained autonomic excitation.
   • Autonomic Storm: Massive release of endogenous catecholamines (epinephrine, norepinephrine) into the circulation.
   • Cardiovascular & Pulmonary Cascade:
     • Alpha-1 adrenergic stimulation leads to severe systemic vasoconstriction, marked increase in systemic vascular resistance (afterload), left ventricular strain, and sudden elevation of left atrial and pulmonary capillary wedge pressure.
     • Direct toxic myocarditis (catecholamine-induced myocardial stunning and subendocardial ischemia) reduces myocardial contractility.
     • Massive pulmonary capillary fluid extravasation ensues, exacerbated by kinin-mediated increase in pulmonary vascular permeability.
4. Specific Therapy & Dosing:
   • Drug of Choice: Prazosin (oral selective postsynaptic $\alpha_1$-adrenergic receptor antagonist).
   • Mechanism: Blocks peripheral alpha-1 receptors $\rightarrow$ reduces systemic vascular resistance (decreases afterload) and venous return (decreases preload) without reflex tachycardia $\rightarrow$ halts and reverses pulmonary edema.
   • Dose:
     • Initial dose: $30\ \mu\text{g/kg/dose}$ orally (or crushed via nasogastric tube).
     • Repeat dose: $30\ \mu\text{g/kg/dose}$ after 3 hours, then every 6 hours until peripheral circulation improves.
   • Titration Endpoints: Resolution of peripheral vasoconstriction (warm extremities, normal capillary refill time $< 2$ seconds), cessation of sweating, reduction in blood pressure and tachycardia, and resolution of tachypnea/crackles.
   • Specific Antivenom: Scorpion Antivenom (SAV) monovalent/polyvalent: 30 to 50 mL diluted in 100 mL normal saline IV over 30 minutes, administered within 4 hours of the sting.

1. Radiological Sign & Anatomical Basis:
   • Thymic Sail Sign (also known as the sail sign of the normal thymus).
   • Anatomical Basis: Represents a triangular, sharply delineated lateral extension of the normal, pliable thymus into the right or left anterior mediastinum, demarcated inferiorly by the minor (horizontal) fissure.
2. Differentiating Characteristics from Pathological Masses:
   • Absence of Mass Effect: Does not compress or displace the trachea, carina, or mediastinal vascular structures despite its large size.
   • Thymic Wave Sign (Mulberry Sign): Scalloping or undulation of the lateral borders created by the gentle impression of adjacent anterior ribs due to physiological thymic plasticity.
3. Conditions Associated with Involution or Absence:
   • Severe Acute Systemic Stress: Sepsis, severe burns, prolonged mechanical ventilation, or major surgical stress (corticosteroid-mediated involution).
   • Exogenous Systemic Corticosteroid Therapy: Rapid atrophy after systemic steroid administration.
   • Primary Immunodeficiencies: DiGeorge syndrome (22q11.2 deletion syndrome), severe combined immunodeficiency (SCID), ataxia-telangiectasia.
   • Normal Age-related Involution: Physiological pubertal involution.
4. Management and Follow-up:
   • Reassurance: Parental counseling that this represents a benign, healthy, physiological finding in infancy.
   • No Interventions: No further radiological imaging (repeat radiographs, computed tomography, or ultrasound) and no antibiotics or bronchodilators are required.

1. Radiological Findings:
   • Hyperinflated lungs with flattened, depressed diaphragms (>8 posterior ribs visible).
   • Prominent perihilar vascular streakiness ("sunburst" pattern) representing engorged lymphatic channels.
   • Fluid accumulation within the interlobar fissures (particularly the horizontal fissure) and mild cardiomegaly.
2. Probable Clinical Diagnosis:
   • Transient Tachypnea of the Newborn (TTN) (also termed Wet Lung Syndrome / Retained Fetal Lung Liquid Syndrome).
3. Pathophysiological Mechanism:
   • Delayed clearance and resorption of fetal alveolar lung fluid.
   • Normal transition requires catecholamine and steroid-driven upregulation of Apithelial Sodium Channels (ENaC) located on apical alveolar epithelial cells, which switch from active chloride secretion to active sodium and fluid absorption into the interstitium and pulmonary lymphatic network.
   • Absence of labor-associated thoracic squeezing and lacking the maternal/fetal adrenergic surge (as in elective LSCS without prior labor) impairs ENaC activation, resulting in alveolar fluid retention and decreased pulmonary compliance.
4. Clinical Management Protocol:
   • Supportive Respiratory Care: Heated Humidified High-Flow Nasal Cannula (HFNC) or low-pressure Nasal CPAP (4–5 $\text{cm H}_2\text{O}$) with targeted $\text{SpO}_2$ titration between 91% and 95%.
   • Fluid Management: Restrict total fluid intake on Day 1 of life to $60\text{ mL/kg/day}$ (maintenance level) to prevent fluid overload while clearance takes place.
   • Enteral Feeding Safety: Withhold oral direct breast/bottle feeds if respiratory rate $>70\text{ breaths/minute}$; provide expressed breast milk via orogastric tube or maintain intravenous $10\%$ dextrose infusion. Routine antibiotics are discontinued once blood cultures are sterile at 48 hours.

1. Radiological Sign & Diagnosis:
   • Sign: "Egg-on-a-string" or "egg-on-side" appearance (narrow superior mediastinal vascular pedicle with cardiomegaly).
   • Diagnosis: d-Transposition of the Great Arteries (d-TGA).
2. Anatomical Basis of the Narrow Vascular Pedicle:
   • The aorta arises anteriorly and directly in front of the pulmonary artery (anteroposterior relationship rather than normal side-by-side spiral arrangement).
   • Stress-induced thymic atrophy or hypoplasia.
   • Hyperinflated lungs causing mediastinal stretching.
3. Mathematical Calculation:
   $$ > \begin{aligned} > \text{Concentration of solution} &= \frac{500\text{ mcg}}{50\text{ mL}} = 10\text{ mcg/mL} \\ > \text{Dose required} &= 0.05\text{ mcg/kg/min} \times 3.1\text{ kg} = 0.155\text{ mcg/min} \\ > \text{Hourly drug requirement} &= 0.155\text{ mcg/min} \times 60\text{ min} = 9.3\text{ mcg/hr} \\ > \text{Infusion Rate} &= \frac{9.3\text{ mcg/hr}}{10\text{ mcg/mL}} = \mathbf{0.93\text{ mL/hr}} > \end{aligned} > $$
4. Interventions:
   • Emergency Bedside Palliative Procedure: Rashkind Balloon Atrial Septostomy (BAS) under transthoracic echocardiographic guidance to enlarge the interatrial communication.
   • Definitive Corrective Surgery: Arterial Switch Operation (Jatene Procedure), ideally performed within the first 2 to 3 weeks of life (before left ventricular mass regresses due to falling pulmonary vascular resistance).

1. Differentiating MRI Features:
   • Size: Tuberculomas are typically $>20\text{ mm}$ in diameter, often multilocular/conglomerate; NCC is usually solitary or oligolesional and $<20\text{ mm}$ in diameter.
   • Wall Thickness and Margin: Tuberculoma has a thick, irregular, nodular ring of enhancement; NCC typically exhibits a thin, uniform, smooth regular ring.
   • T2-Weighted Signal of Core: Tuberculoma has a solid caseating center with central T2-hypointensity (due to high cellularity and paramagnetic free radicals); NCC has a cystic fluid core that is hyperintense on T2-weighted sequences.
   • Pathognomonic Internal Feature: NCC frequently demonstrates a mural eccentric nodule representing the invaginated scolex ("hole-with-a-dot" sign); tuberculoma lacks a scolex.
2. MR Spectroscopy (MRS) Findings in Tuberculoma:
   • Markedly elevated Lipid/Lactate peaks (at 0.9 and 1.3 ppm) reflecting rich lipid content of mycobacterial cell walls and central caseous necrosis.
   • Marked reduction/depletion of normal neuronal markers: N-acetylaspartate (NAA), Creatine (Cr), and variable Choline (Cho).
3. Medical Management for Solitary Parenchymal Neurocysticercosis:
   • Albendazole: $15\text{ mg/kg/day}$ divided every 12 hours (maximum $800\text{ mg/day}$) orally with a fatty meal for 14 days.
   • Antiseizure Medication: Levetiracetam ($20\text{–}30\text{ mg/kg/day}$) or Carbamazepine ($10\text{–}15\text{ mg/kg/day}$), continued until lesion resolution on follow-up neuroimaging and seizure-free for at least 6 to 12 months.
4. Corticosteroid Co-administration Protocol:
   • Indication: Mandatory concurrent administration starting 1–2 days prior to cysticidal therapy to suppress host inflammatory reaction provoked by dying cysticerci and prevent rebound cerebral edema/seizures.
   • Regimen: Prednisolone at $1\text{ to }2\text{ mg/kg/day}$ orally (or Dexamethasone $0.1\text{ mg/kg/dose}$ Q6H IV/PO) initiated 24–48 hours before Albendazole, continued throughout the 14-day antiparasitic course, and subsequently tapered over 1 to 2 weeks.

1. Differential Diagnosis of Unilateral Hyperlucent Lung:
   • Congenital/Developmental Causes:
     • Congenital Lobar Emphysema (CLE) / Congenital Lobar Overinflation.
     • Congenital Pulmonary Airway Malformation (CPAM, predominantly large cyst Type 1).
     • Swyer-James-MacLeod Syndrome (post-infectious bronchiolitis obliterans).
     • Congenital unilateral pulmonary artery hypoplasia or absence.
   • Acquired Causes:
     • Foreign body aspiration with check-valve air trapping.
     • Tension pneumothorax or large simple pneumothorax.
     • Mucus plugging or endobronchial mass (carcinoid, endobronchial TB).
2. Pathophysiological Mechanism of Mediastinal Shift:
   • Ball-Valve / Check-Valve Phenomenon: Incomplete bronchial occlusion permits bronchial dilation during inspiration (allowing air entry), but luminal collapse during expiration traps air distal to the obstruction.
   • Radiographic Dynamics: On expiration, normal lung deflates and decreases in volume, whereas the obstructed hyperinflated lung remains air-trapped, resulting in marked mediastinal shift away from the affected side and flattening/depression of the ipsilateral hemidiaphragm.
3. Procedural Checklist for Rigid Bronchoscopy Retrieval:
   • Pre-procedure:
     • Maintain nil-per-os (NPO) status; keep patient in position of comfort; ensure pre-oxygenation.
     • Obtain informed high-risk surgical consent, prepare blood cross-match, and verify appropriate age-sized rigid ventilating bronchoscopes (e.g., sizes 3.5 and 4.0) with matching optical grasping forceps.
   • Anesthesia & Airway Setup:
     • Total Intravenous Anesthesia (TIVA) with Propofol/Remifentanil while preserving spontaneous ventilation if possible; avoid positive-pressure over-ventilation to prevent complete obstruction or distal impaction.
     • Pre-medicate with Glycopyrrolate ($5\text{ mcg/kg}$) to dry secretions and Dexamethasone ($0.25\text{–}0.5\text{ mg/kg}$) to prevent post-extubation laryngeal edema.
   • Intervention & Extraction:
     • Introduce the rigid bronchoscope under direct optical visualization, avoiding displacement of foreign material into the contralateral bronchus.
     • Grasp foreign object firmly with optical peanut-grasping forceps; extract the bronchoscope, forceps, and foreign body simultaneously as a single unit through the vocal cords.
   • Post-procedure Care:
     • Re-enter with bronchoscope to inspect the tracheobronchial tree for retained fragments, mucosal tear, or distal hemorrhage; obtain a surveillance chest radiograph to exclude pneumothorax and evaluate resolution of air trapping.

Algorithm for Pediatric Foreign Body Aspiration

graph TD
    A[Acute choking/coughing episode + Unilateral wheeze/air trapping] --> B{Patient Stable?}
    B -- No: Severe Hypoxia / Arrest --> C[Immediate BLS / Back blows / Laryngoscopy]
    B -- Yes --> D[Expiratory Chest Radiographs: Frontal & Lateral Decubitus]
    D --> E{Radiographic Findings}
    E -- Radiopaque FB / Ball-valve Hyperlucency / Atelectasis --> F[Rigid Optical Bronchoscopy in OR]
    E -- Normal radiograph but high clinical index of suspicion --> F
    F --> G[Extract FB + Re-scope for secondary fragments]
    G --> H[Post-op Dexamethasone + Chest Physiotherapy]